The pituitary gland

Sylvia L. Asa; Ozgur Mete

Chapter 12 - The pituitary gland

from Section III - Anatomical endocrine pathology

Published online by Cambridge University Press: 13 April 2017

Sylvia L. Asa and

Ozgur Mete

Edited by

Ozgur Mete and

Sylvia L. Asa

Show author details

Ozgur Mete: Affiliation:
University of Toronto
Sylvia L. Asa: Affiliation:
University of Toronto

Book contents

Get access

Type: Chapter
Information: Endocrine Pathology , pp. 315 - 397

Publisher: Cambridge University Press

Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ferrand, R, Pearse, AGE, Polak, JM, Le Douarin, NM. Immunohistochemical studies on the development of avian embryo pituitary corticotrophs under normal and experimental conditions. Histochemistry 1974;38:133–141.Google Scholar

Takor Takor, T, Pearse, AGE. Neuroectodermal origin of avian hypothalamohypophysial complex: the role of the ventral neural ridge. J Embryol Exp Morphol 1975;34:311–325.Google Scholar

Asa, SL, Kovacs, K. Functional morphology of the human fetal pituitary. Pathology Annual 1984;19:275–315.Google Scholar

Boyd, JD. Observations of the human pharyngeal hypophysis. J Endocrinol 1956;14:66–77.Google Scholar

Melchionna, RH, Moore, RA. The pharyngeal pituitary gland. Am J Pathol 1938;14:763–771.Google Scholar

Hori, A. Suprasellar peri-infundibular ectopic adenohypophysis in fetal and adult brains. J Neurosurg 1985;62:113–115.Google Scholar

Lloyd, RV, Chandler, WF, Kovacs, K, Ryan, N. Ectopic pituitary adenomas with normal anterior pituitary glands. Am J Surg Pathol 1986;108:546–552.CrossRef Google Scholar

Coire, CI, Horvath, E, Kovacs, K, Smyth, HS, Ezzat, S. Cushing’s syndrome from an ectopic pituitary adenoma with peliosis: A histological, immunohistochemical and ultrastructural study and review of the literature. Endocr Pathol 1997;8:65–74.CrossRef Google Scholar PubMed

Colohan, ART, Grady, MS, Bonnin, JM, Thorner, MO, Kovacs, K, Jane, JA. Ectopic pituitary gland simulating a suprasellar tumor. Neurosurgery 1987;20:43–48.Google Scholar

Schochet, SS Jr., McCormick, WF, Halmi, NS. Salivary gland rests in the human pituitary. Light and electron microscopical study. Arch Pathol 1974;98:193–200.Google Scholar

Kato, T, Aida, T, Abe, H, et al. Ectopic salivary gland within the pituitary gland. Case report. Neurol Med Chir 1988;28:930–933.Google Scholar

Asa, SL, Ezzat, S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998;19:798–827.Google Scholar PubMed

Asa, SL, Ezzat, S. Molecular determinants of pituitary cytodifferentiation. Pituitary 1999;1:159–168.Google Scholar

Scully, KM, Rosenfeld, MG. Pituitary development: regulatory codes in mammalian organogenesis. Science 2002;295:2231–2235.CrossRef Google Scholar PubMed

Sheng, HZ, Moriyama, K, Yamashita, T, et al. Multistep control of pituitary organogenesis. Science 1997;278:1809–1812.CrossRef Google Scholar PubMed

Sornson, MW, Wu, W, Dasen, JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996;384:327–333.CrossRef Google Scholar PubMed

Ehrlich, RM. Ectopic and hypoplastic pituitary with adrenal hypoplasia. J Pediatr 1957;51:377–384.Google Scholar

Moncrieff, MW, Hill, DS, Archer, J, Arthur, LJH. Congenital absence of pituitary gland and adrenal hypoplasia. Arch Dis Child 1972;47:136–137.Google Scholar

Kauschansky, A, Genel, M, Walker Smith, GJ. Congenital hypopituitarism in female infants. Its association with hypoglycemia and hypothyroidism. Am J Dis Child 1979;133:165–169.CrossRef Google Scholar PubMed

Kosaki, K, Matsuo, N, Tamai, S, Miyama, S, Momoshima, S. Isolated aplasia of the anterior pituitary as a cause of congenital panhypopituitarism. Horm Res 1991;35:226–228.Google Scholar

Pholsena, M, Young, J, Couzinet, B, Schaison, G. Primary adrenal and thyroid insufficiencies associated with hypopituitarism: A diagnostic challenge. Clin Endocrinol (Oxf) 1994;40:693–695.Google Scholar

Dorsett, D, Krantz, ID. On the molecular etiology of Cornelia de Lange syndrome. Ann N Y Acad Sci 2009;1151:22–37.CrossRef Google Scholar PubMed

Fujita, K, Matsuo, N, Mori, O, et al. The association of hypopituitarism with small pituitary, invisible stalk, type 1 Arnold–Chiari malformation, and syringomyelia in several patients born in breech position: a further proof of birth injury theory on the pathogenesis of “idiopathic hypopituitarism.” Eur J Pediatr 1992;151:266–270.Google Scholar

Dattani, MT, Martinez-Barbera, JP, Thomas, PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125–133.Google Scholar

Kelberman, D, Rizzoti, K, Avilion, A, et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo–pituitary–gonadal axis in mice and humans. J Clin Invest 2006;116:2442–2455.Google Scholar PubMed

Priesel, A. Uber die dystopie der neurohyophyse. Virchows Arch Pathol Anat Physiol Klin Med 1927;266:407–415.Google Scholar

Roessmann, U. Duplication of the pituitary gland and spinal cord. Arch Pathol Lab Med 1985;109:518–520.Google Scholar

Netchine, I, Sobrier, ML, Krude, H, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000;25:182–186.Google Scholar

Dattani, MT. The candidate gene approach to the diagnosis of monogenic disorders. Horm Res 2009;71(suppl 2):14–21.Google Scholar

Machinis, K, Pantel, J, Netchine, I, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001;69:961–968.Google Scholar

Pfäffle, RW, Hunter, CS, Savage, JJ, et al. Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. J Clin Endocrinol Metab 2008;93:1062–1071.Google Scholar

Wu, W, Cogan, JD, Pfäffle, RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998;18:147–149.Google Scholar

Fofanova, O, Takmura, N, Kinoshita, E, et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601–2604.Google Scholar

Tatsumi, K, Miyai, K, Notomi, T, et al. Cretinism with combined hormone deficiency caused by a mutation in the Pit-1 gene. Nat Genet 1992;1:56–58.CrossRef Google Scholar

Pfäffle, RW, DiMattia, GE, Parks, JS, et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257:1118–1121.Google Scholar

Radovick, S, Nations, M, Du, Y, Berg, LA, Weintraub, BD, Wondisford, FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;257:1115–1118.Google Scholar

Li, S, Crenshaw, EB, III, Rawson, EJ, Simmons, DM, Swanson, LW, Rosenfeld, MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 1990;347:528–533.Google Scholar

Celli, G, LaRochelle, WJ, Mackem, S, Sharp, R, Merlino, G. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 1998;17:1642–1655.Google Scholar

Roh, M, Paterson, AJ, Asa, SL, Chin, E, Kudlow, JE. Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol Endocrinol 2001;15:600–613.Google Scholar

Raetzman, LT, Cai, JX, Camper, SA. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 2007;304:455–466.Google Scholar

Ezzat, S, Mader, R, Yu, S, Ning, T, Poussier, P, Asa, SL. Ikaros integrates endocrine and immune system development. J Clin Invest 2005;115:1021–1029.CrossRef Google Scholar PubMed

Ezzat, S, Mader, R, Fischer, S, Yu, S, Ackerley, C, Asa, SL. An essential role for the hematopoietic transcription factor Ikaros in hypothalamic–pituitary–mediated somatic growth. Proc Natl Acad Sci USA 2006;103:2214–2219.Google Scholar

Pilavdzic, D, Kovacs, K, Asa, SL. Pituitary morphology in anencephalic human fetuses. Neuroendocrinology 1997;65:164–172.Google Scholar

Elster, AD. Modern imaging of the pituitary. Radiology 1993;187:1–14.CrossRef Google Scholar PubMed

Lurie, SN, Doraiswamy, PM, Husain, MM, et al. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 1990;71:505–508.Google Scholar

Bergland, RM, Ray, BS, Torack, RM. Anatomical variations in the pituitary gland and adjacent structures in 225 human autopsy cases. J Neurosurg 1968;28:93–99.Google Scholar

Elster, AD, Sanders, TG, Vines, FS. Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 1991;181:531–535.Google Scholar

Asa, SL, Penz, G, Kovacs, K, Ezrin, C. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med 1982;106:360–363.Google Scholar

Jordan, RM, Kendall, JW, Kerber, CW. The primary empty sella syndrome. Analysis of the clinical characteristics, radiographic features, pituitary function and cerebrospinal fluid adenohypophysial hormone concentrations. Am J Med 1977;62:569–580.CrossRef Google Scholar PubMed

Bergeron, C, Kovacs, K, Bilbao, JM. Primary empty sella. A histologic and immunocytologic study. Arch Intern Med 1979;139:248–249.CrossRef Google Scholar PubMed

Gharib, H, Frey, HM, Laws, ER Jr., Randall, RV, Scheithauer, BW. Coexistent primary empty sella syndrome and hyperprolactinemia. Report of 11 cases. Arch Intern Med 1983;143:1383–1386.CrossRef Google Scholar PubMed

Asa, SL, Kovacs, K, Bilbao, JM. The pars tuberalis of the human pituitary. A histologic, immunohistochemical, ultrastructural and immunoelectron microscopic analysis. Virchows Arch A Pathol Anat Histopathol 1983;399:49–59.CrossRef Google Scholar PubMed

Wislocki, GB. The vascular supply of the hypophysis cerebri of the rhesus monkey and man. Res Publ Assoc Nerv Ment Dis 1938;17:48–68.Google Scholar

Stanfield, JP. The blood supply of the human pituitary gland. J Anat 1960;94:257–273.Google Scholar

Sheehan, HL, Davis, JC. Pituitary necrosis. Br Med Bull 1968;24:59–70.Google Scholar

Daniel, PM, Prichard, MML. Observations on the vascular anatomy of the pituitary gland and its importance in pituitary function. Am Heart J 1966;72:147–152.Google Scholar

Bergland, RM, Page, RB. Can the pituitary secrete directly to the brain? Affirmative anatomical evidence. Endocrinology 1978;102:1325–1338.Google Scholar

Bergland, RM, Page, RB. Pituitary–brain vascular relations: a new paradigm. Science 1979;204:18–24.CrossRef Google Scholar PubMed

Gorczyca, W, Hardy, J. Arterial supply of the human anterior pituitary gland. Neurosurgery 1987;20:368–369.Google Scholar

Rosenfeld, MG. POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev 1991;5:897–907.Google Scholar

Steinfelder, HJ, Radovick, S, Wondisford, FE. Hormonal regulation of the thyrotropin b-subunit gene by phosphorylation of the pituitary–specific transcription factor Pit-1. Proc Natl Acad Sci USA 1992;89:5942–5945.Google Scholar

Asa, SL, Puy, LA, Lew, AM, Sundmark, VC, Elsholtz, HP. Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1993;77:1275–1280.Google Scholar

Friend, KE, Chiou, Y-K, Laws, ER Jr., Lopes, MBS, Shupnik, MA. Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 1993;77:1281–1286.Google Scholar

Pellegrini, I, Barlier, A, Gunz, G, et al. Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994;79:189–196.Google Scholar

Zafar, M, Ezzat, S, Ramyar, L, Pan, N, Smyth, HS, Asa, SL. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 1995;80:3621–3627.Google Scholar

Friend, KE, Chiou, YK, Lopes, MBS, Laws, ER Jr., Hughes, KM, Shupnik, MA. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 1994;78:1497–1504.Google Scholar

Chaidarun, SS, Klibanski, A, Alexander, JM. Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1058–1065.Google Scholar PubMed

Day, RN, Koike, S, Sakai, M, Muramatsu, M, Maurer, RA. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 1990;4:1964–1971.CrossRef Google Scholar PubMed

Drolet, DW, Scully, KM, Simmons, DM, et al. TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis defines a new class of leucine zipper proteins. Genes Dev 1991;5:1739–1753.Google Scholar

Dasen, JS, O’Connell, SM, Flynn, SE, et al. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999;97:587–598.Google Scholar

Stefaneanu, L, Kovacs, K, Lloyd, RV, et al. Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 1992;62:291–296.Google Scholar

Horvath, E, Lloyd, RV, Kovacs, K. Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 1990;63:511–520.Google Scholar

Lamolet, B, Pulichino, AM, Lamonerie, T, et al. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001;104:849–859.Google Scholar

Pulichino, AM, Vallette-Kasic, S, Couture, C, et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003;17:711–716.Google Scholar

Lamonerie, T, Tremblay, JJ, Lanctot, C, Therrien, M, Gauthier, Y, Drouin, J. Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 1996;10:1284–1295.Google Scholar

Therrien, M, Drouin, J. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 1993;13:2342–2353.Google Scholar

Poulin, G, Turgeon, B, Drouin, J. NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 1997;17:6673–6682.Google Scholar

Lala, DS, Rice, DA, Parker, KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992;6:1249–1258.Google Scholar

Honda, S-I, Morohashi, K-I, Nomura, M, Takeya, H, Kitajima, M, Omura, T. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993;268:7494–7502.Google Scholar

Luo, X, Ikeda, Y, Parker, KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481–490.Google Scholar

Asa, SL, Bamberger, A-M, Cao, B, Wong, M, Parker, KL, Ezzat, S. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 1996;81:2165–2170.Google Scholar

Asa, SL, Ryan, N, Kovacs, K, Singer, W, Marangos, PJ. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas. Arch Pathol Lab Med 1984;108:40–43.Google Scholar

Stefaneanu, L, Ryan, N, Kovacs, K. Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 1988;112:801–804.Google Scholar

Lloyd, RV, Cano, M, Rosa, P, Hille, A, Huttner, WB. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 1988;130:296–304.Google Scholar

Trouillas, J, Guigard, MP, Fonlupt, P, Souchier, C, Girod, C. Mapping of corticotropic cells in the normal human pituitary. J Histochem Cytochem 1996;44:473–479.Google Scholar

Smith, AI, Funder, JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 1988;9:159–179.Google Scholar

Girod, C, Trouillas, J. Hypophyse: Embryologie, Anatomie et Histologie. Paris: Editions Scientifiques et Médicales, 1993.Google Scholar

Marcinkiewicz, M, Day, R, Seidah, NG, Chretien, M. Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin. Proc Natl Acad Sci USA 1993;90:4922–4926.Google Scholar

Takumi, I, Steiner, DF, Sanno, N, Teramoto, A, Osamura, RY. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Mod Pathol 1998;11:232–238.Google Scholar

Neumann, PE, Horoupian, DS, Goldman, JE, Hess, MA. Cytoplasmic filaments of Crooke’s hyaline change belong to the cytokeratin class. An immunocytochemical and ultrastructural study. Am J Pathol 1984;116:214–222.Google Scholar

Coons, SW, Estrada, SI, Gamez, R, White, WL. Cytokeratin CK7 and CK20 expression in pituitary adenomas. Endocr Pathol 2005;16:201–210.Google Scholar

Eschbacher, JM, Coons, SW. Cytokeratin CK20 is a sensitive marker for Crooke’s cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs. Endocr Pathol 2006;17:365–376.Google Scholar

Horvath, E, Ilse, G, Kovacs, K. Enigmatic bodies in human corticotroph cells. Acta Anat (Basel) 1977;98:427–433.Google Scholar

Kovacs, K, Horvath, E, Ryan, N. Immunocytology of the human pituitary. In DeLellis, RA, ed. Diagnostic Immunohistochemistry. New York: Masson, 1981: 17–35.Google Scholar

Asa, SL, Kovacs, K, Laszlo, FA, Domokos, I, Ezrin, C. Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology 1986;43:308–316.Google Scholar

Asa, SL, Kovacs, K, Horvath, E, et al. Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 1988;48:423–431.Google Scholar

Carey, RM, Varma, SK, Drake, CR Jr., et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing’s syndrome. A clinical, morphologic, and biochemical study. N Engl J Med 1984;311:13–20.Google Scholar

Asa, SL, Kovacs, K, Hammer, GD, Liu, B, Roos, BA, Low, MJ. Pituitary corticotroph hyperplasia in rats implanted with a medullary thyroid carcinoma cell line transfected with a corticotropin-releasing hormone complementary deoxyribonucleic acid expression vector. Endocrinology 1992;131:715–720.Google Scholar

Siperstein, ER, Allison, VF. Fine structure of the cells responsible for secretion of adrenocorticotrophin in the adrenalectomized rat. Endocrinology 1965;76:70–79.Google Scholar

Scheithauer, BW, Kovacs, K, Randall, RV. The pituitary gland in untreated Addison’s disease. A histologic and immunocytologic study of 18 adenohypophyses. Arch Pathol Lab Med 1983;107:484–487.Google Scholar

Crooke, AC. A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 1935;41:339–349.Google Scholar

Horvath, E, Kovacs, K. Fine structural cytology of the adenohypophysis in rat and man. J Electron Microsc Tech 1988;8:401–432.Google Scholar

Baker, BL, Dermody, WC, Reell, JR. Localization of luteinizing hormone-releasing hormone in the mammalian hypothalamus. Am J Anat 1974;139:129–134.Google Scholar

Yang, H-J, Ozawa, H, Kurosumi, K. Ultrastructural changes in growth hormone cells in the rat anterior pituitary after thyroidectomy as studied by immunoelectron microscopy and enzyme histochemistry. J Clin Electr Microsc 1989;22:269–283.Google Scholar

Scheithauer, BW, Sano, T, Kovacs, KT, Young, WF Jr., Ryan, N, Randall, RV. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461–474.Google Scholar

Serri, O, Chik, CL, Ur, E, Ezzat, S. Diagnosis and management of hyperprolactinemia. CMAJ 2003;169:575–581.Google Scholar

Scheithauer, BW, Kovacs, K, Randall, RV, Ryan, N. Effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 1989;64:1077–1084.Google Scholar

Frawley, LS, Boockfor, FR. Mammosomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 1991;12:337–355.Google Scholar

Losinski, NE, Horvath, E, Kovacs, K, Asa, SL. Immunoelectron microscopic evidence of mammosomatotrophs in human adult and fetal adenohypophyses, rat adenohypophyses and human and rat pituitary adenomas. Anat Anz 1991;172:11–16.Google Scholar

Lloyd, RV, Anagnostou, D, Cano, M, Barkan, AL, Chandler, WF. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry. J Clin Endocrinol Metab 1988;66:1103–1110.Google Scholar

Scheithauer, BW, Kovacs, K, Randall, RV, Ryan, N. Pituitary gland in hypothyroidism. Histologic and immunocytologic study. Arch Pathol Lab Med 1985;109:499–504.Google Scholar

Horvath, E, Kovacs, K. The adenohypophysis. In Kovacs, K, Asa, SL, eds. Functional Endocrine Pathology. Boston, MA: Blackwell Scientific, 1991:245–281.Google Scholar

Kovacs, K, Sheehan, HL. Pituitary changes in Kallman’s syndrome: a histologic, immunocytologic, ultrastructural, and immunoelectronmicroscopic study. Fertil Steril 1982;37:83–89.Google Scholar

Horvath, E, Kovacs, K, Penz, G, Ezrin, C. Origin, possible function and fate of “follicular cells” in the anterior lobe of the human pituitary. Am J Pathol 1974;77:199–212.Google Scholar

Yamashita, M, Qian, ZR, Sano, T, Horvath, E, Kovacs, K. Immunohistochemical study on so-called follicular cells and folliculostellate cells in the human adenohypophysis. Pathol Int 2005;55:244–247.Google Scholar

Höfler, H, Walter, GF, Denk, H. Immunohistochemistry of folliculo-stellate cells in normal human adenophypophyses and in pituitary adenomas. Acta Neuropathol (Berl) 1984;65:35–40.CrossRef Google Scholar

Girod, C, Trouillas, J, Dubois, MP. Immunocytochemical localization of S100 protein in stellate cells (folliculo-stellate cells) of the anterior lobe of the normal human pituitary. Cell Tissue Res 1985;241:505–511.Google Scholar

Coates, PJ, Doniach, I. Development of folliculo-stellate cells in the human pituitary. Acta Endocrinol (Copenh) 1988;119:16–20.Google Scholar

Lee, EB, Tihan, T, Scheithauer, BW, Zhang, PJ, Gonatas, NK. Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol 2009;68:482–488.Google Scholar

Vankelecom, H, Carmeliet, P, van Damme, J, Billiau, A, Denef, C. Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 1989;49:102–106.Google Scholar

Ferrara, N, Schweigerer, L, Neufeld, G, Mitchell, R, Gospodarowicz, D. Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 1987;84:5773–5777.Google Scholar

Baes, M, Allaerts, W, Denef, C. Evidence for functional communication between folliculo-stellate cells and hormone-secreting cells in perifused anterior pituitary aggregates. Endocrinology 1987;120:685–691.Google Scholar

Nishioka, H, Llena, JF, Hirano, A. Immunohistochemical study of folliculostellate cells in pituitary lesions. Endocr Pathol 1991;2:155–160.Google Scholar

Lauriola, L, Cocchia, D, Sentinelli, S, Maggiano, N, Maira, G, Michetti, F. Immunohistochemical detection of folliculo-stellate cells in the human pituitary. Virchows Arch B Cell Pathol Incl Mol Pathol 1984;47:189–197.Google Scholar

Marin, F, Kovacs, K, Stefaneanu, L, Horvath, E, Cheng, Z. S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas. Endocr Pathol 1992;3:28–38.Google Scholar

Vankelecom, H, Chen, J. Pituitary stem cells: where do we stand? Mol Cell Endocrinol 2014;385:2–17.CrossRef Google Scholar PubMed

Kovacs, K, Horvath, E, Bilbao, JM. Oncocytes in the anterior lobe of the human pituitary gland. A light and electron microscopic study. Acta Neuropathol (Berl) 1974;27:43–54.Google Scholar

Mete, O, Lopes, MB, Asa, SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 2013;37:1694–1699.Google Scholar

Kimura, S, Hara, Y, Pineau, T, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60–69.Google Scholar

Takuma, N, Sheng, HZ, Furuta, Y, et al. Formation of Rathke’s pouch requires dual induction from the diencephalon. Develop 1998;125:4835–4840.Google Scholar

Takei, Y, Seyama, S, Pearl, GS, Tindall, GT. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes. Cell Tissue Res 1980;205:273–287.Google Scholar

Costello, RT. Subclinical adenoma of the pituitary gland. Am J Pathol 1936;12:205–215.Google Scholar

Kovacs, K, Ryan, N, Horvath, E, Singer, W, Ezrin, C. Pituitary adenomas in old age. J Gerontol 1980;35:16–22.Google Scholar

Burrow, GN, Wortzman, G, Rewcastle, NB, Holgate, RC, Kovacs, K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156–158.Google Scholar

Parent, AD, Brown, B, Smith, EE. Incidental pituitary adenomas: a retrospective study. Surgery 1982;92:880–883.Google Scholar

McComb, DJ, Ryan, N, Horvath, E, Kovacs, K. Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 1983;107:488–491.Google Scholar

Adelman, LS, Post, KD. Intra-operative frozen section technique for pituitary adenomas. Am J Surg Pathol 1979;3:173–175.Google Scholar

Velasco, ME, Sindely, SO, Roessmann, U. Reticulum stain for frozen-section diagnosis of pituitary adenomas. J Neurosurg 1977;46:548–550.Google Scholar

McKeever, PE, Laverson, S, Oldfield, EH, Smith, BH, Gadille, D, Chandler, WF. Stromal and nuclear markers for rapid identification of pituitary adenomas at biopsy. Arch Pathol Lab Med 1985;109:509–514.Google Scholar

Lang, H-D, Saeger, W, Lüdecke, DK, Muller, D. Rapid frozen section diagnosis of pituitary tumors. Endocr Pathol 1990;1:116–122.Google Scholar

Lloyd, RV. Frozen sections in the diagnosis of pituitary lesions. In Lloyd, RV, ed. Surgical Pathology of the Pituitary Gland. Philadelphia, PA: WB Saunders, 1993:22–24.Google Scholar

Adams, H, Graham, DI, Doyle, D. Brain Biopsy. The Smear Technique for Neurosurgical Biopsies. Philadelphia PA: Lippincott, 1981.Google Scholar

Marshall, LF, Adams, H, Doyle, D, Graham, DI. The histological accuracy of the smear technique for neurosurgical biopsies. J Neurosurg 1973;39:82–88.Google Scholar

Martinez, A-J, Moossy, J. Cytological diagnosis of pituitary adenomas. J Neuropathol Exp Neurol 1983;412:307–311.Google Scholar

Lüdecke, DK. Intraoperative measurement of adrenocorticotropic hormone in peripituitary blood in Cushing’s disease. Neurosurgery 1989;24:201–205.Google Scholar

Stefaneanu, L, Kovacs, K. Light microscopic special stains and immunohistochemistry in the diagnosis of pituitary adenomas. In Lloyd, RV, ed. Surgical Pathology of the Pituitary Gland. Philadelphia, PA: WB Saunders, 1993: 34–51.Google Scholar

Thorner, MO, Perryman, RL, Cronin, MJ, et al. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 1982;70:965–977.Google Scholar

Jarzembowski, J, Lloyd, R, McKeever, P. Type IV collagen immunostaining is a simple, reliable diagnostic tool for distinguishing between adenomatous and normal pituitary glands. Arch Pathol Lab Med 2007;131:931–935.Google Scholar

Bilbao, JM, Horvath, E, Hudson, AR, Kovacs, K. Pituitary adenoma producing amyloid-like substance. Arch Pathol Lab Med 1975;99:411–415.Google Scholar

Landolt, AM, Kleihues, P, Heitz, PU. Amyloid deposits in pituitary adenomas. Differentiation of two types. Arch Pathol Lab Med 1987;111:453–458.Google Scholar

Bilbao, JM, Kovacs, K, Horvath, E, et al. Pituitary melanocorticotrophinoma with amyloid deposition. J Can Sci Neurol 1975;2:199–202.Google Scholar

Mori, H, Mori, S, Saitoh, Y, Moriwaki, K, Iida, S, Matsumoto, K. Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohistochemically positive for growth hormone. Cancer 1985;55:96–102.Google Scholar

Voigt, C, Saeger, W, Gerigk, Ch, Lüdecke, DK. Amyloid in pituitary adenomas. Pathol Res Pract 1988;183:555–557.Google Scholar

Giannattasio, G, Bassetti, M. Human pituitary adenomas. Recent advances in morphological studies. J Endocrinol Invest 1990;13:435–454.Google Scholar

Labat-Moleur, F, Trouillas, J, Seret-Begue, D, Kujas, M, Delisle, M-B, Ronin, C. Evaluation of 29 monoclonal and polyclonal antibodies used in the diagnosis of pituitary adenomas. A collaborative study from pathologists of the Club Français de l’Hypophyse. Pathol Res Pract 1991;187:534–538.Google Scholar

Al Shraim, M, Asa, SL. The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol 2006;111:1–7.Google Scholar

Mete, O, Asa, SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol 2012;22:443–453.Google Scholar

Nosé, V, Ezzat, S, Horvath, E, et al. Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med 2011;135:640–646.Google Scholar

Ciocca, DR, Puy, LA, Stati, AO. Identification of seven hormone-producing cell types in the human pharyngeal hypophysis. J Clin Endocrinol Metab 1985;60:212–216.Google Scholar

Björklöf, K, Brundelet, PJ. Typus degenerativus amstelodamensis (Cornelia de Lange first syndrome). Congenital hypopituitarism due to a cyst of Rathke’s cleft? Acta Pediatr Scand 1965;54:275–287.Google Scholar

Kelberman, D, Rizzoti, K, Lovell-Badge, R, Robinson, IC, Dattani, MT. Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 2009;30:790–829.Google Scholar

Alatzoglou, KS, Webb, EA, Le Tissier, P, Dattani, MT. Isolated growth hormone deficiency (GHD) in childhood and adolescence: recent advances. Endocr Rev 2014;35:376–432.Google Scholar

Dode, C, Hardelin, JP. Clinical genetics of Kallmann syndrome. Ann Endocrinol (Paris) 2010;71:149–157.Google Scholar

Fraietta, R, Zylberstejn, DS, Esteves, SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo) 2013;68(suppl 1):81–88.Google Scholar

Tubridy, N, Saunders, D, Thom, M, et al. Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J Neurol Neurosurg Psychiatry 2001;71:798–801.Google Scholar

Cheung, CC, Ezzat, S, Smyth, HS, Asa, SL. The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 2001;86:1048–1053.Google Scholar

Glauber, HS, Brown, BM. Pituitary macroadenoma associated with intrasellar abscess: a case report and review. Endocrinologist 1992;2:169–172.Google Scholar

Berger, SA, Edberg, SC, David, G. Infectious disease in the sella turcica. Rev Infect Dis 1986;5:747–755.Google Scholar

Sano, T, Kovacs, K, Scheithauer, BW, Rosenblum, MK, Petito, CK, Greco, CM. Pituitary pathology in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1989;113:1066–1070.Google Scholar

Veseley, DL, Maldonodo, A, Levey, GS. Partial hypopituitarism and possible hypothalamic involvement in sarcoidosis. Report of a case and review of the literature. Am J Med 1977;62:425–431.Google Scholar

Toth, M, Szabo, P, Racz, K, et al. Granulomatous hypophysitis associated with Takayasu’s disease. Clin Endocrinol 1996;45:499–503.Google Scholar

Lohr, KM, Ryan, L.M., Toohill, RJ, Anderson, T. Anterior pituitary involvement in Wegener’s granulomatosis. J Rheumatol 1988;15:855–861.Google Scholar

De Bruin, WI, van’t Verlaat, JW, Graamans, K, De Bruin, TWA. Sellar granulomatous mass in a pregnant woman with active Crohn’s disease. Neth J Med 1991;39:136–141.Google Scholar

Albini, CH, MacGillvray, MHFJE, Woorhess, ML, Klein, DM. Triad of hypopituitarism, granulomatous hypophysitis, and ruptured Rathke’s cleft cyst. Neurosurg 1988;22:133–136.Google Scholar

Cannavò, S, Romaon, C, Calbucci, F, Faglia, G. Granulomatous sarcoidotic lesion of hypothalamic–pituitary region associated with Rathke’s cleft cyst. J Enocrinol Invest 1997;20:77–81.Google Scholar

Yoshioka, M, Yamakawa, N, Sarro, H, et al. Granulomatous hypophysitis with meningitis and hypopituitarism. Intern Med 1992;31:1147–1150.Google Scholar

Carpenter, KJ, Murtagh, RD, Lilienfeld, H, Weber, J, Murtagh, FR. Ipilimumab-induced hypophysitis: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1751–1753.Google Scholar

Barnard, ZR, Walcott, BP, Kahle, KT, Nahed, BV, Coumans, JV. Hyponatremia associated with Ipilimumab-induced hypophysitis. Med Oncol 2012;29:374–377.Google Scholar

Goudie, RB, Pinkerton, PH. Anterior hypophysitis and Hashimoto’s disease in a young woman. J Pathol Bacteriol 1962;83:584–585.Google Scholar

Asa, SL, Bilbao, JM, Kovacs, K, Josse, RG, Kreines, K. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Ann Intern Med 1981;95:166–171.Google Scholar

McCutcheon, IE, Oldfield, EH. Lymphocytic adenohypophysitis presenting as infertility. J Neurosurg 1991;74:821–826.Google Scholar

Portocarrero, CJ, Robinson, AG, Taylor, AL, Klein, I. Lymphoid hypophysitis. An unusual cause of hyperprolactinemia and enlarged sella turcica. J Am Med Assoc 1981;246:1811–1812.Google Scholar

Hughes, JM, Ellsworth, CA, Harris, BS. Clinical case seminar: a 33-year-old woman with a pituitary mass and panhypopituitarism. J Clin Endocrinol Metab 1995;80:1521–1525.Google Scholar

Masana, Y, Ikeda, H, Fujimoto, Y, et al. Lymphocytic adenohypohysitis: case report. Neurol Med Chir 1990;30:853–857.Google Scholar

Burke, CW, Moore, RA, Rees, LH, Bottazzo, GF, Mashiter, K, Bitensky, L. Isolated ACTH deficiency and TSH deficiency in the adult. J Royal Soc Med 1979;72:328–335.Google Scholar

Richtsmeier, AJ, Henry, RA, Bloodworth, JMB Jr., Ehrlich, EN. Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med 1980;140:1243–1245.Google Scholar

Roosens, B, Maes, E, van Steirteghem, A, Vanhaelst, L. Primary hypothyroidism associated with secondary adrenocortical insufficiency. J Endocrinol Invest 1982;5:251–254.Google Scholar

Vandeput, Y, Orth, DN, Crabbe, J. Combined primary and secondary adrenocortical failure. Ann Endocrinol (Paris) 1982;43:277–279.Google Scholar

Barkan, AL, Kelch, RP, Marshall, JC. Isolated gonadotrope failure in the polyglandular autoimmune syndrome. N Engl J Med 1985;312:1535–1540.Google Scholar

Jensen, MD, Handwerger, BS, Scheithauer, BW, Carpenter, PC, Mirakian, R, Banks, PM. Lymphocytic hypophysitis with isolated corticotropin deficiency. Ann Intern Med 1986;105:200–203.Google Scholar

Sauter, NP, Toni, R, McLaughlin, CD, Dyess, EM, Kritzmanm, J, Lechan, RM. Isolated adrenocorticotropin deficiency associated with an autoantibody to corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 1990;70:1391–1397.Google Scholar

Escobar-Morreale, H, Serrano-Gotarredona, J, Varela, C. Isolated adrenocorticotropic hormone deficiency due to probable lymphocytic hypophysitis in a man. J Endocrinol Invest 1994;17:127–131.Google Scholar

Thodou, E, Asa, SL, Kontogeorgos, G, Kovacs, K, Horvath, E, Ezzat, S. Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302–2311.Google Scholar

Imura, H, Nakao, K, Shimatsu, A, et al. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 1993;329:683–689.Google Scholar

Abe, T, Matsumoto, K, Sanno, N, Osamura, Y. Lymphocytic hypophysitis: case report. Neurosurgery 1995;36:1016–1019.Google Scholar

Ludwig, H, Schernthaner, G. Multiorganspezifische Autoimmunität bei idiopathischer Nebennierenrindeninsuffizienz. Wein Klin Wochenschr 1978;90:736–741.Google Scholar

Mayfield, RK, Levine, JH, Gordon, L, Powers, J, Galbraith, RM, Rawe, SE. Lymphoid adenohypophysitis presenting as a pituitary tumor. Am J Med 1980;69:619–623.Google Scholar

Wild, RA, Kepley, M. Lymphocytic hypophysitis in a patient with amenorrhea and hyperprolactinemia. J Repro Med 1986;31:211–216.Google Scholar

Ozawa, Y, Shishiba, Y. Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies. Acta Endocrinol (Copenh) 1993;128:493–498.Google Scholar

Crock, PA. Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 1998;83:609–618.Google Scholar

Crock, P, Salvi, M, Miller, A, Wall, J, Guyda, H. Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods 1993;162:31–40.Google Scholar

Manetti, L, Lupi, I, Morselli, LL, et al. Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J Clin Endocrinol Metab 2007;92:2176–2181.Google Scholar

Komatsu, M, Kondo, T, Yamauchi, K, et al. Antipituitary antibodies in patients with the primary empty sella syndrome. J Clin Endocrinol Metab 1988;67:633–638.Google Scholar

Bottazzo, GF, McIntosh, C, Stanford, W, Preece, M. Growth hormone cell antibodies and partial growth hormone deficiency in a girl with Turner’s syndrome. Clin Endocrinol (Oxf) 1980;12:1–9.Google Scholar

Bensing, S, Kasperlik-Zaluska, AA, Czarnocka, B, Crock, PA, Hulting, A. Autoantibodies against pituitary proteins in patients with adrenocorticotropin-deficiency. Eur J Clin Invest 2005;35:126–132.Google Scholar

Scherbaum, WA, Schrell, U, Glück, M, Fahlbusch, R, Pfeiffer, EF. Autoantibodies to pituitary corticotropin-producing cells: Possible marker for unfavourable outcome after pituitary microsurgery for Cushing’s disease. Lancet 1987;i:1394–1398.Google Scholar

Bottazzo, GF, Pouplard, A, Florin-Christensen, A, Doniach, D. Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 1975;ii:97–101.Google Scholar

O’Dwyer, DT, Smith, AI, Matthew, ML, et al. Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase. J Clin Endocrinol Metab 2002;87:752–757.Google Scholar

O’Dwyer, DT, Clifton, V, Hall, A, Smith, R, Robinson, PJ, Crock, PA. Pituitary autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-enolase: a link with pregnancy? Arch Physiol Biochem 2002;110:94–98.Google Scholar

Guay, AT, Agnello, V, Tronic, BC, Gresham, DG, Freidberg, SR. Lymphocytic hypophysitis in a man. J Clin Endocrinol Metab 1987;64:631–634.Google Scholar

Pestell, RG, Best, JD, Alford, FP. Lymphocytic hypophysitis. the clinical spectrum of the disorder and evidence for an autoimmune pathogenesis. Clin Endocrinol (Oxf) 1990;33:457–466.Google Scholar

Supler, ML, Mickle, JP. Lymphocytic hypophysitis: report of a case in a man with cavernous sinus involvement. Surg Neurol 1992;37:472–476.Google Scholar

Feigenbaum, SL, Martin, MC, Wilson, CB, Jaffe, RB. Lymphocytic adenohypophysitis: a pituitary mass lesion occurring in pregnancy. Proposal for medical treatment. Am J Obstet Gynecol 1991;164:1549–1555.Google Scholar

Meichner, RH, Riggio, S, Manz, HJ, Earll, JM. Lymphocytic adenohypophysitis causing pituitary mass. Neurology 1987;37:158–161.Google Scholar

Miyamoto, M, Sugawa, H, Mori, T, Hashimoto, N, Imura, H. A case of hypopituitarism due to granulomatous and lymphocytic adenohypophysitis with minimal pituitary enlargement: a possible variant of lymphocytic adenohypophysitis. Endocrinol Jpn 1988;35:607–616.Google Scholar

Peterson, P, Peltonen, L. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. J Autoimmun 2005;25(suppl:49–55.Google Scholar

Bensing, S, Fetissov, SO, Mulder, J, et al. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci USA 2007;104:949–954.Google Scholar

Hasimoto, K, Takao, T, Makino, S. Lymphocytic andenohypophysitis and lymphocytic infundibuloneurohypophysitis. Endocr J 1997;44:1–10.Google Scholar

Kamel, N, Dagci Illgin, S, Corapicioglu, D, Deda, H, Gullu, S. Lymphocytic infundibuloneurohypophysitis presenting as diabetes insipidus in a man. J Endocrinol Invest 1998;21:537–540.Google Scholar

Reusch, JE-B, Kleinschmidt-De Masters, BK, Lillehei, KO, Rappe, D, Gutierrez-Hartmann, A. Preoperative diagnosis of lymphocytic hypophysitis (adenohypophysitis) unresponsive to short course dexamethasone: case report. Neurosurgery 1992;30:268–272.Google Scholar

Nishioka, H, Ito, H, Miki, T, Akada, K. A case of lymphocytic hypophysitis with massive fibrosis and the role of surgical intervention. Surg Neurol 1994;42:74–78.Google Scholar

Mikami, T, Uozumi, T. Lymphocytic adenohypophysitis: MRI findings of a suspected cases. No Shinkei Geka 1989;176:871–876.Google Scholar

Ikeda, H, Okudaira, Y. Spontaneous regression of pituitary mass in temporal association with pregnancy. Neuroradiology 1987;29:488–492.Google Scholar

McGrail, KM, Beyerl, BD, Black, PM, Klibanski, A, Zervas, NT. Lymphocytic adenohypophysitis of pregnancy with complete recovery. Neurosurgery 1987;20:791–793.Google Scholar

Ober, KP, Elster, A. Spontaneously resolving lymphocytic hypophysitis as a cause of postpartum diabetes insipidus. The Endocrinologist 1994;4:107–111.Google Scholar

Bevan, JS, Othman, S, Lazarus, JH, Parkes, AB, Hall, R. Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. J Clin Endocrinol Metab 1992;74:548–552.Google Scholar

Ishihara, T, Nakatsu, S, Hino, M, et al. A case of pregnancy-induced lymphocytic adenophypophysitis complicated by postpartum painless thyroiditis. Nippon Naibunpi Gakkai Zasshi 1991;67:222–229.Google Scholar

Bitton, RN, Slavin, M, Decker, RE, Zito, J, Schneider, BS. The course of lymphocytic hypophysitis. Surg Neurol 1991;36:40–43.Google Scholar

Nussbaum, CE, Okawara, S-H, Jacobs, LS. Lymphocytic hypophysitis with involvement of the cavernous sinus and hypothalamus. Neurosurgery 1991;28:440–444.Google Scholar

Stelmach, M, O’Day, J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis. J Clin Neurol Ophthalmol 1991;11:19–24.Google Scholar

Prasad, A, Madan, VS, Sethi, PK, Prasad, ML, Buxi, TBS, Kanwar, CK. Lymphocytic hypophysitis: can open exploration of the sella be avoided? Br J Neurosurg 1991;5:639–642.Google Scholar

Quencer, RM. Lymphocytic adenohypophysitis: autoimmune disorder of the pituitary gland. AJNR Am J Neuroradiol 1980;1:343–345.Google Scholar

Levine, SN, Benzel, EC, Fowler, MR, Shroyer, JVI, Mirfakhraee, M. Lymphocytic hypophysitis: clinical, radiological and magnetic resonance imaging characterization. Neurosurgery 1988;22:937–941.Google Scholar

Mazzone, T, Kelly, W, Ensinck, J. Lymphocytic hypophysitis associated with antiparietal cell antibodies and vitamin B₁₂ deficiency. Arch Intern Med 1983;143:1794–1795.Google Scholar

McConnon, JK, Smyth, HS, Horvath, E. A case of sparsely granulated growth hormone cell adenoma associated with lymphocytic hypophysitis. J Endocrinol Invest 1991;14:691–696.Google Scholar

Miura, M, Ushio, Y, Kuratsu, J, Ikeda, J, Kai, Y, Yamashiro, S. Lymphocytic adenohypophysitis: report of two cases. Surg Neurol 1989;32:463–470.Google Scholar

Rickards, AG, Harvey, PW. “Giant cell granuloma” and the other pituitary granulomata. Quarterly J Med 1954;23:425–440.Google Scholar

Taylon, C, Duff, TA. Giant cell granuloma involving the pituitary gland. Case report. J Neurosurg 1980;52:584–587.Google Scholar

Del Pozo, JM, Roda, JE, Montoya, JG, Iglesias, JR, Hurtado, A. Intrasellar granuloma. Case report. J Neurosurg 1980;53:717–719.Google Scholar

Hassoun, P, Anayssi, E, Salti, I. A case of granulomatous hypophysitis with hypopituitarism and minimal pituitary enlargement. J Neurol Neurosurg Psychiatry 1985;48:949–951.Google Scholar

Higuchi, M, Arita, N, Mori, S, Satoh, B, Mori, H, Hayakawa, T. Pituitary granuloma and chronic inflammation of hypophysis: clinical and immunohistochemical studies. Acta Neurochir (Wien) 1993;121:152–158.Google Scholar

Scanarini, M, d’Ercole, AJ, Rotilio, A, Kitromilis, N, Mingrino, S. Giant-cell granulomatous hypophysitis: a distinct clinicopathological entity. J Neurosurg 1989;71:681–686.Google Scholar

Oeckler, RCT, Bise, K. Non-specific granulomas of the pituitary: report of six cases treated surgically. Neurosurg Rev 1991;14:185–190.Google Scholar

Holck, S, Laursen, H. Prolactinoma coexistent with granulomatous hypophysitis. Acta Neuropathol (Berl) 1983;61:253–257.Google Scholar

Saeger, W, Hofmann, BM, Buslei, R, Buchfelder, M. Silent, ACTH cell adenoma in coincidence with granulomatous hypophysitis: a case report. Pathol Res Pract 2007;203:221–225.Google Scholar

Murakami, M, Nishioka, H, Izawa, H, Ikeda, Y, Haraoka, J. Granulomatous hypophysitis associated with rathke’s cleft cyst: a case report. Minim Invasive Neurosurg 2008;51:169–172.Google Scholar

Inoue, T, Kaneko, Y, Mannoji, H, Fukui, M. Giant cell granulomatous hypophysitis manifesting as an intrasellar mass with unilateral ophthalmoplegia. Neurol Med Chir (Tokyo) 1997;37:766–770.Google Scholar

Vasile, M, Marsot-Dupuch, K, Kujas, M, et al. Idiopathic granulomatous hypophysitis: clinical and imaging features. Neuroradiology 1997;39:7–11.Google Scholar

Jastania, R, Nageeti, T, Kovacs, K, Ezzat, S, Asa, SL. Granulomatous hypophysitis with psammoma bodies: a diagnostic dilemma. Endocr Pathol 2004;15:359–363.Google Scholar

Rossi, GP, Pavan, E, Chiesura-Corona, M, Rea, F, Poletti, A, Pessina, AC. Bronchocentric granulomatosis and central diabetes insipidus successfully treated with corticosteroids. Eur Resp J 1994;7:1893–1898.Google Scholar

Folkerth, RD, Price, DL, Schwartz, M, Black, PM, De Girolami, U. Xanthomatous hypophysitis. Am J Surg Pathol 1998;22:736–741.Google Scholar

Deodhare, SS, Bilbao, JM, Kovacs, K, et al. Xanthomatous Hypophysitis: a novel entity of obscure etiology. Endocr Pathol 1999;10:237–241.Google Scholar

Burt, MG, Morey, AL, Turner, JJ, Pell, M, Sheehy, JP, Ho, KK. Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 2003;6:161–168.Google Scholar

Tashiro, T, Sano, T, Xu, B, et al. Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr Pathol 2002;13:183–195.Google Scholar

Gartman, JJ Jr., Powers, SK, Fortune, M. Pseudotumor of the sellar and parasellar areas. Neurosurgery 1989;24:896–901.Google Scholar

Al Shraim, M, Syro, LV, Kovacs, K, Estrada, H, Uribe, H, Al Gahtany, M. Inflammatory pseudotumor of the pituitary: case report. Surg Neurol 2004;62:264–267.Google Scholar

Wong, S, Lam, WY, Wong, WK, Lee, KC. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 2007;38:1720–1723.CrossRef Google Scholar PubMed

Livadas, DP, Sofroniadou, K, Souvatzoglou, A, Boulanger, V, Siafaka, L, Koutras, DA. Pituitary and thyroid insufficiency in thalassaemic haemosiderosis. Clin Endocrinol 1979;20:435–443.Google Scholar

Kletzky, OA, Costin, G, Marrs, RP, Bernstein, G, March, CM, Mishell, DR Jr. Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab 1979;48:901–905.Google Scholar

Yoshino, A, Katayama, Y, Watanabe, T, et al. Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests. Acta Neurochir (Wien) 2007;149:557–565.Google Scholar

Nawar, RN, AbdelMannan, D, Selman, WR, Arafah, BM. Pituitary tumor apoplexy: a review. J Intens Care Med 2008;23:75–90.Google Scholar

Keyaki, A, Hirano, A, Llena, JF. Asymptomatic and symptomatic Rathke’s cleft cysts. Neurol Med Chir 1989;29:88–93.Google Scholar

Shin, JL, Asa, SL, Woodhouse, LJ, Smyth, HS, Ezzat, S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 1999;84:3972–3982.Google Scholar

Steinberg, GK, Koenig, GH, Golden, JB. Symptomatic Rathke’s cleft cysts. Report of two cases. J Neurosurg 1982;56:290–295.Google Scholar

Voelker, JL, Campbell, RL, Muller, J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg 1991;74:535–544.Google Scholar

Le, BH, Towfighi, J, Kapadia, SB, Lopes, MB. Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol 2007;18:23–30.Google Scholar

Barrow, DL, Spector, RH, Takei, Y, Tindall, GT. Symptomatic Rathke’s cleft cysts located entirely in the suprasellar region: review of diagnosis, management and pathogenesis. Neurosurgery 1985;16:766–772.Google Scholar

Kepes, JJ. Transitional cell tumor of the pituitary gland developing from a Rathke’s cleft cyst. Cancer 1978;41:337–343.Google Scholar

Nishio, S, Mizuno, J, Barrow, DL, Takei, Y, Tindall, GT. Pituitary tumors composed of adenohypophysial adenoma and Rathke’s cleft cyst elements: a clinicopathological study. Neurosurgery 1987;21:371–377.Google Scholar

Nakasu, S, Nakasu, Y, Kyoshima, K, Watanabe, K, Handa, J, Okabe, H. Pituitary adenoma with multiple ciliated cysts: transitional cell tumor? Surg Neurol 1989;31:41–48.Google Scholar

Obenchain, TG, Becker, DP. Abscess formation in a Rathke’s cleft cyst. Case report. J Neurosurg 1972;36:359–362.Google Scholar

Meyer, FB, Carpenter, SM, Laws, ER Jr. Intrasellar arachnoid cysts. Surg Neurol 1987;28:105–110.Google Scholar

Spaziante, R. Intrasellar arachnoid cysts. Surg Neurol 1988;30:412–413.Google Scholar

Jones, RFC, Warnock, TH, Nayanar, V, Gupta, JM. Suprasellar arachnoid cysts: management by cyst wall resection. Neurosurgery 1989;25:554–561.Google Scholar

Yamakawa, K, Shitara, N, Genka, S, Manaka, S, Takakura, K. Clinical course and surgical prognosis of 33 cases of intracranial epidermoid tumors. Neurosurgery 1989;24:568–573.Google Scholar

Chhang, WH, Sharma, BS, Singh, K, Suri, S, Marwaha, RK, Kak, VK. A middle fossa arachnoid cyst in association with a suprasellar dermoid cyst. Indian J Pediatr 1989;26:833–835.Google Scholar

Abramson, RC, Morawetz, RB, Schlitt, M. Multiple complications from an intracranial epidermoid cyst: case report and literature review. Neurosurgery 1989;24:574–578.Google Scholar

Lewis, AJ, Cooper, PW, Kassel, EE, Schwartz, ML. Squamous cell carcinoma arising in a suprasellar epidermoid cyst. Case report. J Neurosurg 1983;59:538–541.Google Scholar

Dussault, J, Plamondon, C, Volpe, R. Aneurysms of the internal carotid artery simulating pituitary tumours. CMAJ 1969;101:51–56.Google Scholar

Seda, JL, Cukiert, A, Nogueira, KC, Huayllas, MK, Liberman, B. Intrasellar internal carotid aneurysm coexisting with GH-secreting pituitary adenoma in an acromegalic patient. Arq Neuropsiquiatr 2008;66:99–100.Google Scholar

Soni, A, De Silva, SR, Allen, K, Byrne, JV, Cudlip, S, Wass, JA. A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy. Pituitary 2008;11:307–311.Google Scholar

Torres, A, Dammers, R, Krisht, AF. Bilateral internal carotid artery aneurysm simulating pituitary apoplexy: case report. Neurosurgery 2009;65:E1202.Google Scholar

Durham, LH, Mackenzie, IJ, Miles, JB. Transphenoidal meningohydroencephalocoele. Br J Neurosurg 1988;2:407–410.Google Scholar

Oka, H, Kameya, T, Sasano, H, et al. Pituitary choristoma composed of corticotrophs and adrenocortical cells in the sella turcica. Virchows Arch A Pathol Anat Histopathol 1996;427:613–617.Google Scholar

Hampton, TA, Scheithauer, BW, Rojiani, AM, Kovacs, K, Horvath, E, Vogt, P. Salivary gland-like tumors of the sellar region. Am J Surg Pathol 1997;21:424–434.Google Scholar

Gilcrease, MZ, Delgado, R, Albores-Saavedra, J. Intrasellar adenoid cystic carcinoma and papillary mucinous adenocarcinoma: two previously undescribed primary neoplasms at this site. Ann Diagn Pathol 1999;3:141–147.Google Scholar

van Furth, W, Smyth, HS, Horvath, E, Kovacs, K, Salehi, F, Cusimano, MD. Salivary gland-like tumor of the sella. Can J Neurol Sci 2007;34:478–482.Google Scholar

Mete, O, Ng, T, Christie-David, D, McMaster, J, Asa, SL. Silent corticotroph adenoma with adrenal cortical choristoma: a rare but distinct morphological entity. Endocr Pathol 2013;24:162–166.Google Scholar

Shenker, Y, Lloyd, RV, Weatherbee, L, Port, FK, Grekin, RJ, Barkan, AL. Ectopic prolactinoma in a patient with hyperparathyroidism and abnormal sellar radiography. J Clin Endocrinol Metab 1986;62:1065–1069.Google Scholar

Weinstein, LS, Shenker, A, Gejman, PV, Merino, MJ, Friedman, E, Spiegel, AM. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med 1991;325:1688–1695.Google Scholar

Kovacs, K, Horvath, E, Thorner, MO, Rogol, AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune–Albright syndrome. Virchows Arch A Pathol Anat Histopathol 1984;403:77–86.Google Scholar

Ezzat, S, Asa, SL, Stefaneanu, L, et al. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 1994;78:555–560.Google Scholar

Barkan, AL, Shenker, Y, Grekin, RJ, Vale, WW, Lloyd, RV, Beals, TF. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab 1986;63:1057–1064.Google Scholar

Khalil, A, Kovacs, K, Sima, AAF, Burrow, GN, Horvath, E. Pituitary thyrotroph hyperplasia mimicking prolactin-secreting adenoma. J Endocrinol Invest 1984;7:399–404.Google Scholar

Chan, AW, MacFarlane, IA, Foy, PM, Miles, JB. Pituitary enlargement and hyperprolactinaemia due to primary hypothyroidism: errors and delays in diagnosis. Br J Neurosurg 1990;4:107–112.Google Scholar

Saeger, W, Lüdecke, DK. Pituitary hyperplasia. Definition, light and electron microscopical structures and significance in surgical specimens. Virchows Arch A Pathol Anat Histopathol 1983;399:277–287.Google Scholar

Thorner, MO, Frohman, LA, Leong, DA, et al. Extrahypothalamic growth hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 1984;59:846–849.Google Scholar

Moran, A, Asa, SL, Kovacs, K, et al. Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med 1990;323:322–327.Google Scholar

McKeever, PE, Koppelman, MCS, Metcalf, D, et al. Refractory Cushing’s disease caused by multinodular ACTH-cell hyperplasia. J Neuropathol Exp Neurol 1982;41:490–499.Google Scholar

McNicol, AM. Patterns of corticotropic cells in the adult human pituitary in Cushing’s disease. Diagn Histopathol 1981;4:335–341.Google Scholar

Fjellestad-Paulsen, A, Abrahamsson, P-A, Bjartell, A, et al. Carcinoma of the prostate with Cushing’s syndrome. A case report with immunohistochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumor tissue. Acta Endocrinol (Copenh) 1988;119:506–516.Google Scholar

Jessop, DS, Cunnah, D, Millar, JGB, et al. A phaeochromocytoma presenting with Cushing’s syndrome associated with increased concentrations of circulating corticotrophin-releasing factor. J Endocrinol 1987;113:133–138.Google Scholar

Schteingart, DE, Lloyd, RV, Akil, H, et al. Cushing’s syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab 1986;63:770–775.Google Scholar

Zárate, A, Kovacs, K, Flores, M, Morán, C, Félix, I. ACTH and CRF-producing bronchial carcinoid associated with Cushing’s syndrome. Clin Endocrinol (Oxf) 1986;24:523–529.Google Scholar

Asa, SL, Kovacs, K, Vale, W, Petrusz, P, Vecsei, P. Immunohistologic localization of corticotrophin-releasing hormone in human tumors. Am J Clin Pathol 1987;87:327–333.Google Scholar

Birkenhäger, JC, Upton, GV, Seldenrath, HJ, Kreiger, DT, Tashjian, AH Jr. Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities. Acta Endocrinol (Copenh) 1976;83:280–292.Google Scholar

Asa, SL, Kovacs, K, Tindall, GT, Barrow, DL, Horvath, E, Vecsei, P. Cushing’s disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor. Ann Intern Med 1984;101:789–793.Google Scholar

Puchner, MJA, Lüdecke, DK, Valdueza, JM, et al. Cushing’s disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma. Neurosurgery 1993;33:920–925.Google Scholar

Kubota, T, Hayashi, M, Kabuto, M, et al. Corticotroph cell hyperplasia in a patient with Addison disease: case report. Surg Neurol 1992;37:441–447.Google Scholar

Zhou, J, Ruan, L, Li, H, Wang, Q, Zheng, F, Wu, F. Addison’s disease with pituitary hyperplasia: a case report and review of the literature. Endocrine 2009;35:285–289.Google Scholar

Simpson, DJ, McNicol, AM, Murray, DC, et al. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing’s disease. Clin Cancer Res 2004;10:1780–1788.Google Scholar

Sano, T, Asa, SL, Kovacs, K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 1988;9:357–373.Google Scholar

Faglia, G, Arosio, M, Bazzoni, N. Ectopic acromegaly. Endocrinol Metab Clin North Am 1992;21:575–595.Google Scholar

Othman, NH, Ezzat, S, Kovacs, K, et al. Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly. Clin Endocrinol (Oxf) 2001;55:135–140.Google Scholar

Doga, M, Bonadonna, S, Burattin, A, Giustina, A. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Ann Oncol 2001;12(suppl 2):S89–S94.Google Scholar

Asa, SL, Scheithauer, BW, Bilbao, JM, et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 1984;58:796–803.Google Scholar

Billestrup, N, Swanson, LW, Vale, W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 1986;83:6854–6857.Google Scholar

Stefaneanu, L, Kovacs, K, Horvath, E, et al. Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. Endocrinology 1989;125:2710–2718.Google Scholar

Mayo, KE, Hammer, RE, Swanson, LW, Brinster, RL, Rosenfeld, MG, Evans, RM. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 1988;2:606–612.Google Scholar

Nasr, C, Mason, A, Mayberg, M, Staugaitis, SM, Asa, SL. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab 2006;91:4776–4780.Google Scholar

Asa, SL, Kovacs, K, Stefaneanu, L, et al. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 1992;131:2083–2089.Google Scholar

Asa, SL, Kovacs, K, Stefaneanu, L, et al. Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Proc Soc Exp Biol Med 1990;193:232–235.Google Scholar

Zimmerman, D, Young, WF Jr., Ebersold, MJ, et al. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 1993;76:216–222.Google Scholar

Lloyd, RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 1983;113:198–206.Google Scholar

Jay, V, Kovacs, K, Horvath, E, Lloyd, RV, Smyth, HS. Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization. Acta Neuropathol (Berl) 1991;82:147–151.Google Scholar

Peillon, F, Dupuy, M, Li, JY, et al. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease. J Clin Endocrinol Metab 1991;73:1008–1015.Google Scholar

Kelly, MA, Rubinstein, M, Asa, SL, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 1997;19:103–113.Google Scholar

Schuff, KG, Hentges, ST, Kelly, MA, et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and-independent mechanisms. J Clin Invest 2002;110:973–981.Google Scholar

Newey, PJ, Gorvin, CM, Cleland, SJ, et al. Mutant prolactin receptor and familial hyperprolactinemia. N Engl J Med 2013;369:2012–2020.Google Scholar

Grubb, MR, Chakeres, D, Malarkey, WB. Patients with primary hypothyroidism presenting as prolactinomas. Am J Med 1987;83:765–769.Google Scholar

Atchison, JA, Lee, PA, Albright, AL. Reversible suprasellar pituitary mass secondary to hypothyroidism. J Am Med Assoc 1989;262:3175–3177.Google Scholar

Nicolis, G, Shimshi, M, Allen, C, Halmi, NS, Kourides, IA. Gonadotropin-producing pituitary adenoma in a man with long-standing primary hypogonadism. J Clin Endocrinol Metab 1988;66:237–241.Google Scholar

Kovacs, K, Horvath, E, Rewcastle, NB, Ezrin, C. Gonadotroph cell adenoma of the pituitary in a woman with long-standing hypogonadism. Arch Gynecol 1980;229:57–65.Google Scholar

Ezzat, S, Asa, SL, Couldwell, WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613–619.Google Scholar

Gold, EB. Epidemiology of pituitary adenomas. Epid Rev 1981;3:163–183.Google Scholar

Scheithauer, BW. Surgical pathology of the pituitary: the adenomas. Part I. Pathol Annu 1984;19:317–374.Google Scholar

Daly, AF, Rixhon, M, Adam, C, Dempegioti, A, Tichomirowa, MA, Beckers, A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006;91:4769–4775.Google Scholar

Fernandez, A, Karavitaki, N, Wass, JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2009.Google Scholar

Wilson, CB, Dempsey, LC. Transsphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurg 1978;48:13–22.Google Scholar

Terada, T, Kovacs, K, Stefaneanu, L, Horvath, E. Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases. Endocr Pathol 1995;6:301–310.Google Scholar

Klibanski, A, Zervas, NT. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 1991;324:822–831.Google Scholar

Kovacs, K, Horvath, E. Atlas of Tumor Pathology, 2nd Series, Fascicle 21: Tumors of the pituitary gland. Washington, DC: Armed Forces Institute of Pathology, 1986.Google Scholar

Feldkamp, J, Santen, R, Harms, E, Aulich, A, Modder, U, Scherbaum, WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas: results of a prospective study. Clin Endocrinol (Oxf) 1999;51:109–113.Google Scholar

Mindermann, T, Wilson, CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994;41:359–364.Google Scholar

Kane, LA, Leinung, MC, Scheithauer, BW, et al. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994;79:1135–1140.Google Scholar

Mukai, K, Seljeskog, EL, Dehner, LP. Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases. J Neurooncol 1986;4:79–89.Google Scholar

Jagannathan, J, Dumont, AS, Jane, JA Jr., Laws, ER Jr. Pediatric sellar tumors: diagnostic procedures and management. Neurosurg Focus 2005;18:E6.Google Scholar

Huang, C, Ezzat, S, Asa, SL, Hamilton, J. Dopaminergic resistant prolactinomas in the peripubertal population. J Pediatr Endocrinol Metab 2006;19:951–953.Google Scholar

Kontogeorgos, G, Kovacs, K, Horvath, E, Scheithauer, BW. Multiple adenomas of the human pituitary. A retrospective autopsy study with clinical implications. J Neurosurg 1991;74:243–247.Google Scholar

Kontogeorgos, G, Scheithauer, BW, Horvath, E, et al. Double adenomas of the pituitary: a clinicopathological study of 11 tumors. Neurosurgery 1992;31:840–849.Google Scholar

Apel, RL, Wilson, RJ, Asa, SL. A composite somatotroph-corticotroph pituitary adenoma. Endocr Pathol 1994;5:240–246.Google Scholar

Kim, K, Yamada, S, Usui, M, Sano, T. Preoperative identification of clearly separated double pituitary adenomas. Clin Endocrinol (Oxf) 2004;61:26–30.Google Scholar

Jastania, RA, Alsaad, KO, Al Shraim, M, Kovacs, K, Asa, SL. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation. Endocr Pathol 2005;16:187–194.Google Scholar

Thodou, E, Kontogeorgos, G, Horvath, E, Kovacs, K, Smyth, HS, Ezzat, S. Asynchronous pituitary adenomas with differing morphology. Arch Pathol Lab Med 1995;119:748–750.Google Scholar

Booth, GL, Redelmeier, DA, Grosman, H, Kovacs, K, Smyth, HS, Ezzat, S. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrinol Metab 1998;83:2291–2295.Google Scholar

Rasmussen, P, Lindholm, J. Ectopic pituitary adenomas. Clin Endocrinol (Oxf) 1979;11:69–74.Google Scholar

Slonim, SM, Haykal, HA, Cushing, GW, Freidberg, SR, Lee, AK. MRI appearances of an ectopic pituitary adenoma: case report and review of the literature. Neuroradiology 1993;35:546–548.Google Scholar

Kikuchi, K, Kowada, M, Sasaki, J, Sageshima, M. Large pituitary adenoma of the sphenoid sinus and the nasopharynx: report of a case with ultrastructural evaluations. Surg Neurol 1994;42:330–334.Google Scholar

Dyer, EH, Civit, T, Abecassis, J-P, Derome, PJ. Functioning ectopic supradiaphragmatic pituitary adenomas. Neurosurgery 1994;43:529–532.Google Scholar

Anand, NK, Osborne, CM, Harkey, HLI. Infiltrative clival pituitary adenoma of ectopic origin. Head Neck Surg 1993;108:178–183.Google Scholar

Lindboe, CF, Unsgard, G, Myhr, G, Scott, H. ACTH and TSH producing ectopic suprasellar pituitary adenoma of the hypothalamic region: case report. Clin Neuropathol 1993;12:138–141.Google Scholar

Matsumura, A, Meguro, K, Doi, M, Tsurushima, H, Tomono, Y. Suprasellar ectopic pituitary adenoma: case report and review of the literature. Neurosurgery 1990;26:681–685.Google Scholar

Kleinschmidt-De Masters, BK, Winston, KR, Rubinstein, D, Samuels, MH. Ectopic pituitary adenomas of the third ventricle. Case report. J Neurosurg 1990;72:139–142.Google Scholar

Asa, SL. Atlas of Tumor Pathology, 4th Series, Fascicle 15: Tumors of the Pituitary Gland. Bethesda, MD: ARP Press, 2011.Google Scholar

Kovacs, K, Horvath, E, Ryan, N, Ezrin, C. Null cell adenoma of the human pituitary. Virchows Arch A Pathol Anat Histopathol 1980;387:165–174.Google Scholar

DeLellis, RA, Lloyd, RV, Heitz, PU, Eng, C, eds. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. Lyon: International Agency for Research on Cancer, 2004.Google Scholar

Amar, AP, Hinton, DR, Krieger, MD, Weiss, MH. Invasive pituitary adenomas: significance of proliferation parameters. Pituitary 1999;2:117–122.Google Scholar

Hardy, J. Transsphenoidal surgery of hypersecreting pituitary tumors. In Kohler, PO, Ross, GT, eds. Diagnosis and Treatment of Pituitary Tumors. (Int. Congress Series No. 303). Amsterdam: Exerpta Medica, 1973:179–198.Google Scholar

Scheithauer, BW, Kovacs, KT, Laws, ER Jr., Randall, RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 1986;65:733–744.Google Scholar

Selman, WR, Laws, ER Jr., Scheithauer, BW, Carpenter, SM. The occurrence of dural invasion in pituitary adenomas. J Neurosurg 1986;64:402–407.Google Scholar

Mete, O, Ezzat, S, Asa, SL. Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 2012;49:69–78.Google Scholar

van der Mey, AG, van Seters, AP, van Krieken, JH, Vielvoye, J, Van Dulken, H, Hulshof, JH. Large pituitary adenomas with extension into the nasopharynx. Report of three cases with a review of the literature. Ann Otol Rhinol Laryngol 1989;98:618–624.Google Scholar

Wong, K, Raisanen, J, Taylor, SL, McDermott, MW, Wilson, CB, Gutin, PH. Pituitary adenoma as an unsuspected clival tumor. Am J Surg Pathol 1995;19:900–903.Google Scholar

Horvath, E, Kovacs, K, Smyth, HS, et al. A novel type of pituitary adenoma: morphological feature and clinical correlations. J Clin Endocrinol Metab 1988;66:1111–1118.Google Scholar

Mete, O, Gomes‐Hernandez, K, Kucharczyk, W, et al. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous, plurihormonal Pit‐1 lineage adenomas. Mod Pathol 2016; in press.Google Scholar

Fitzgibbons, PL, Appley, AJ, Turner, RR, et al. Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior. Cancer 1988;62:1556–1560.Google Scholar

Landolt, AM, Shibata, T, Kleihues, P. Growth rate of human pituitary adenomas. J Neurosurg 1987;67:803–806.Google Scholar

Knosp, E, Kitz, K, Perneczky, A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 1989;25:927–930.Google Scholar

Thapar, K, Kovacs, K, Scheithauer, BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996;38:99–107.Google Scholar

Hsu, DW, Hakim, F, Biller, BMK, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753–761.Google Scholar

Gandour-Edwards, R, Kapadia, SB, Janecka, IP, Martinez, AJ, Barnes, L. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 1995;8:160–164.Google Scholar

Takino, H, Herman, V, Weiss, M, Melmed, S. Purine-binding factor (NM23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 1995;80:1733–1738.Google Scholar

Vidal, S, Kovacs, K, Horvath, E, et al. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Mod Pathol 2002;15:1205–1212.Google Scholar

Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932;50:137–195.Google Scholar

Nelson, DH, Meakin, JW, Thorn, GW. ACTH-producing pituitary tumors following adrenalectomy for Cushing’s syndrome. Ann Intern Med 1960;52:560–569.Google Scholar

Lindsay, JR, Nieman, LK. Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am 2005;34:403–21, x.Google Scholar

Findling, JW, Raff, H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2005;34:385–38, x.Google Scholar

Bertagna, X, Guignat, L, Groussin, L, Bertherat, J. Cushing’s disease. Best Pract Res Clin Endocrinol Metab 2009;23:607–623.Google Scholar

Newell-Price, J, Trainer, P, Besser, M, Grossman, A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998;19:647–672.Google Scholar

Krieger, DT, Luria, M. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing’s disease and Nelson’s syndrome. J Clin Endocrinol Metab 1977;44:361–368.Google Scholar

Yamaji, T, Ishibashi, M, Teramoto, A, Fukushima, T. Hyperprolactinemia in Cushing’s disease and Nelson’s syndrome. J Clin Endocrinol Metab 1984;58:790–795.Google Scholar

Lamberts, SWJ, de Quijada, M, Visser, TJ. Regulation of prolactin secretion in patients with Cushing’s disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro. Neuroendocrinology 1981;32:150–154.Google Scholar

Findling, JW, Aron, DC, Tyrrell, JB, et al. Selective venous sampling for ACTH in Cushing’s syndrome. Differentiation between Cushing’s disease and the ectopic ACTH syndrome. Ann Intern Med 1981;94:647–652.Google Scholar

Oldfield, EH, Chrousos, GP, Schulte, HM, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985;312:100–103.Google Scholar

Oldfield, EH, Doppman, JL, Nieman, LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 1991;325:897–905.Google Scholar

Jin, L, Riss, D, Ruebel, K, et al. Galectin-3 expression in functioning and silent ACTH-producing adenomas. Endocr Pathol 2005;16:107–114.Google Scholar

Felix, IA, Horvath, E, Kovacs, K. Massive Crooke’s hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological and electron microscopic study of three cases. Acta Neurochir 1981;58:235–243.Google Scholar

Horvath, E, Kovacs, K, Josse, R. Pituitary corticotroph cell adenoma with marked abundance of microfilaments. Ultrastruct Pathol 1983;5:249–255.Google Scholar

Franscella, S, Favod-Coune, C-A, Pizzolato, G, et al. Pituitary corticotroph adenoma with Crooke’s hyalinization. Endocr Pathol 1991;2:111–116.Google Scholar

George, DH, Scheithauer, BW, Kovacs, K, et al. Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 2003;27:1330–1336.Google Scholar

Hammer, GD, Tyrrell, JB, Lamborn, KR, et al. Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. J Clin Endocrinol Metab 2004;89:6348–6357.Google Scholar

Kelly, DF. Transsphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s syndrome. Neurosurg Focus 2007;23:E5.Google Scholar

Patil, CG, Prevedello, DM, Lad, SP, et al. Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 2008;93:358–362.Google Scholar

Jane, JA Jr., Vance, ML, Woodburn, CJ, Laws, ER Jr. Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 2003;14:e12.Google Scholar

Oyesiku, NM. Stereotactic radiosurgery for Cushing disease: a review. Neurosurg Focus 2007;23:E14.Google Scholar

Pivonello, R, Petersenn, S, Newell-Price, J, et al. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing’s disease: results from a Phase III study. Clin Endocrinol (Oxf) 2014;81:408–417.Google Scholar

Mohammed, S, Kovacs, K, Mason, W, Smyth, H, Cusimano, MD. Use of temozolomide in aggressive pituitary tumors: case report. Neurosurgery 2009;64:E773–E774.Google Scholar

McCormack, AI, McDonald, KL, Gill, AJ, et al. Low O⁶-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clin Endocrinol (Oxf) 2009;71:226–233.Google Scholar

Raverot, G, Sturm, N, de Fraipont, F, et al. Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 2010;95:4592–4599.Google Scholar

Asimakopoulou, A, Tzanela, M, Koletti, A, Kontogeorgos, G, Tsagarakis, S. Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide. Clin Case Rep 2014;2:1–3.Google Scholar

Marie, P. Sur deux cas d’acromégalie. Hypertrophie singulière non congénitale des extremités supérieures, inférieures et céphaliques. Rev Méd 1886;6:297–333.Google Scholar

Minkowski, O. Ueber einen Fall von Akromegalie. Berl Klin Wochenschr 1887;24:371–374.Google Scholar

Evans, HM, Long, JA. The effect of the anterior lobe administered intraperitoneally upon growth, maturity, and oestrous cycles of the rat. Anat Rec 1921;21:62–63.Google Scholar

Cook, DM, Ezzat, S, Katznelson, L, et al. AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract 2004;10:213–225.Google Scholar

Ezzat, S, Serri, O, Chik, CL, et al. Canadian consensus guidelines for the diagnosis and management of acromegaly. Clin Invest Med 2006;29:29–39.Google Scholar

Beck-Peccoz, P, Bassetti, M, Spada, A, et al. Glycoprotein hormone a-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for a-subunit and GH coexistence in the same tumoral cell. J Clin Endocrinol Metab 1985;61:541–546.Google Scholar

Osamura, RY. Immunoelectron microscopic studies of GH and a subunit in GH secreting pituitary adenomas. Pathol Res Pract 1988;183:569–571.Google Scholar

Oppenheim, DS, Kana, AR, Sangha, JS, Klibanski, A. Prevalence of α-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas. J Clin Endocrinol Metab 1990;70:859–864.Google Scholar

Kontogeorgos, G, Asa, SL, Kovacs, K, Smyth, HS, Singer, W. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro. Acta Endocrinol (Copenh) 1993;129:565–572.Google Scholar

Hagiwara, A, Inoue, Y, Wakasa, K, Haba, T, Tashiro, T, Miyamoto, T. Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation. Radiology 2003;228:533–538.Google Scholar

Osamura, RY, Watanabe, K. Immunohistochemical colocalization of growth hormone (GH) and alpha subunit in human GH secreting pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 1987;411:323–330.Google Scholar

Sano, T, Ohshima, T, Yamada, S. Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas. Pathol Res Pract 1991;187:530–533.Google Scholar

Kontogeorgos, G, Kovacs, K, Scheithauer, BW, Rologis, D, Orphanidis, G. α-Subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly. Mod Pathol 1991;4:191–195.Google Scholar

Trouillas, J, Loras, B, Guigard, MP, Girod, C. α-Subunit secretion by normal and tumoral growth hormone cells in humans. Endocr Pathol 1992;3, S53.Google Scholar

Horvath, E, Kovacs, K. Pathology of acromegaly. Neuroendocrinology 2006;83:161–165.Google Scholar

Obari, A, Sano, T, Ohyama, K, et al. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 2008;19:82–91.Google Scholar

Trouillas, J, Girod, C, Lhéritier, M, Claustrat, B, Dubois, MP. Morphological and biochemical relationships in 31 human pituitary adenomas with acromegaly. Virchows Arch A Pathol Anat Histopathol 1980;389:127–142.Google Scholar

Trouillas, J, Sassolas, G, Guigard, MP, Fonlupt, P, Ansaneli-Naves, L, Perrin, G. Relationships between pathological diagnosis and clinical parameters in acromegaly. Metabolism 1996;45(suppl 1):53–56.Google Scholar

Sano, T, Rong, QZ, Kagawa, N, Yamada, S. Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas. Front Horm Res 2004;32:127–132.Google Scholar

Asa, SL, Kovacs, K, Horvath, E, Singer, W, Smyth, HS. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. J Clin Endocrinol Metab 1992;75:68–75.Google Scholar

Li, J, Stefaneanu, L, Kovacs, K, Horvath, E, Smyth, HS. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 1993;422:193–201.Google Scholar

Frohman, LA. Therapeutic options in acromegaly. J Clin Endocrinol Metab 1991;72:1175–1181.Google Scholar

Fraser, LA, Lee, D, Cooper, P, Van Uum, S. Remission of acromegaly following pituitary apoplexy: case report and review of the literature. Endocr Pract 2009;1–19.Google Scholar

Ezzat, S, Kontogeorgos, G, Redelmeier, DA, Horvath, E, Harris, AG, Kovacs, K. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur J Endocrinol 1995;133:686–690.Google Scholar

Barkan, AL, Kelch, RP, Hopwood, NJ, Beitins, IZ. Treatment of acromegaly with the long-acting somatostatin analog SMS 201–995. J Clin Endocrinol Metab 1988;66:16–23.Google Scholar

Ezzat, S, Horvath, E, Harris, AG, Kovacs, K. Morphological effects of octreotide on growth hormone-producing pituitary adenomas. J Clin Endocrinol Metab 1994;79:113–118.Google Scholar

George, SR, Kovacs, K, Asa, SL, Horvath, E, Cross, EG, Burrow, GN. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma. Clin Endocrinol (Oxf) 1987;26:395–405.Google Scholar

Asa, SL, Felix, I, Kovacs, K, Ramyar, L. Effects of somatostatin on somatotroph adenomas of the human pituitary: an in vitro functional and morphological study. Endocr Pathol 1990;1:228–235.Google Scholar

Kontogeorgos, G, Sambaziotis, D, Piaditis, G, Karameris, A. Apoptosis in human pituitary adenomas: a morphologic and in situ end-labeling study. Mod Pathol 1997;10:921–926.Google Scholar

Kulig, E, Jin, L, Qian, X, et al. Apoptosis in nontumorous and neoplastic human pituitaries: expression of the BCL-2 family of proteins. Am J Pathol 1999;154:767–774.Google Scholar

Drake, WM, Berney, DM, Kovacs, K, Monson, JP. Markers of cell proliferation in a GH-producing adenoma of a patient treated with pegvisomant. Eur J Endocrinol 2005;153:203–205.Google Scholar

Asa, SL, DiGiovanni, R, Jiang, J, et al. A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 2007;67:7505–7511.Google Scholar

Buchfelder, M, Schlaffer, S. Surgical treatment of pituitary tumours. Best Pract Res Clin Endocrinol Metab 2009;23:677–692.Google Scholar

Barnard, LB, Grantham, WG, Lamberton, P, O’Dorisio, TM, Jackson, IMD. Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995). Ann Intern Med 1986;105:856–861.Google Scholar

Ezzat, S, Snyder, PJ, Young, WF, et al. Octreotide treatment of acromegaly. a randomized, multicenter study. Ann Intern Med 1992;117:711–718.Google Scholar

Ezzat, S, Redeimeier, DA, Gnehm, M, Harris, AG. A prospective multicenter octreotide dose response study in the treatment of acromegaly. J Endocrinol Invest 1995;18:364–369.Google Scholar

Spada, A, Arosio, M, Bochicchio, D, et al. Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 1990;71:1421–1426.Google Scholar

Bhayana, S, Booth, GL, Asa, SL, Kovacs, K, Ezzat, S. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 2005;90:6290–6295.Google Scholar

Kopchick, JJ, Parkinson, C, Stevens, EC, Trainer, PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 2002;23:623–646.Google Scholar

Jagannathan, J, Sheehan, JP, Pouratian, N, Laws, ER Jr., Steiner, L, Vance, ML. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 2008;62:1262–1269.Google Scholar

Batisse, M, Raverot, G, Maqdasy, S, et al. Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide. Cancer Invest 2013;31:190–196.Google Scholar

Grasso, LF, Pivonello, R, Colao, A. Investigational therapies for acromegaly. Exp Opin Invest Drugs 2013;22:955–963.Google Scholar

Jenkins, PJ, Mukherjee, A, Shalet, SM. Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006;64:115–121.Google Scholar

Loeper, S, Ezzat, S. Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 2008;9:41–58.Google Scholar

Blackwell, RE. Diagnosis and management of prolactinomas. Fertil Steril 1985;43:5–16.Google Scholar

Frommel, R. Ueber puerperale Atrophie des Uterus. Z Geburtshilfe Gynakol 1882;7:305–313.Google Scholar

Argonz, J, Del Castillo, EB. A syndrome characterized by estrogenic insufficiency, galactorrhea and decreased urinary gonadotropin. J Clin Endocrinol Metab 1953;13:79–87.Google Scholar

Forbes, AP, Henneman, PH, Griswold, GC, Albright, F. Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: comparison with acromegaly and normal lactation. J Clin Endocrinol Metab 1954;14:265–271.Google Scholar

Lewis, UJ, Singh, RNP, Sinha, YN, VanderLaan, WP. Electrophoretic evidence for human prolactin. J Clin Endocrinol Metab 1971;23:153–156.Google Scholar

Guyda, H, Hwang, P, Friesen, H. Immunologic evidence for monkey and human prolactin (MPr and HPr). J Clin Endocrinol Metab 1971;32:120–123.Google Scholar

Grossman, A, Besser, GM. Prolactinomas. Br Med J 1985;290:182–184.Google Scholar

Melmed, S, Braunstein, GD, Chang, RJ, Becker, DP. Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med 1986;105:238–253.Google Scholar

Vance, ML, Thorner, MO. Prolactinomas. Endocrinol Metab Clin North Am 1987;16:731–753.Google Scholar

Nabarro, JDN. Pituitary prolactinomas. Clin Endocrinol (Oxf) 1982;17:129–155.Google Scholar

Grisoli, F, Vincentelli, F, Jaquet, P, Guibout, M, Hassoun, J, Farnarier, P. Prolactin secreting adenoma in 22 men. Surg Neurol 1980;13:241–247.Google Scholar

Delgrange, E, Trouillas, J, Maiter, D, Donckier, J, Tourniaire, J. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102–2107.Google Scholar

Ho, KY, Evans, WS, Thorner, MO. Disorders of prolactin and growth hormone secretion. Clin Endocrinol Metab 1985;14:1–32.Google Scholar

Fields, K, Kulig, E, Lloyd, RV. Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction. Lab Invest 1993;68:354–360.Google Scholar

Gellerson, B, Kempf, R, Telgmann, R, DiMattia, GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994;8:356–373.Google Scholar

Soares, MJ, Faria, TN, Roby, KF, Deb, S. Pregnancy and the prolactin family of hormones: coordination of anterior pituitary, uterine, and placental expression. Endocr Rev 1991;12:402–423.Google Scholar

Hoffman, WH, Galan, RR, Kovacs, K, Subramanian, MG. Ectopic prolactin secretion from a gonadoblastoma. Cancer 1987;60:2690–2695.Google Scholar

Singer, W. Does pituitary stalk compression cause hyperprolactinemia? Endocr Pathol 1990;1:65–67.Google Scholar

Horvath, E, Kovacs, K, Singer, W, Ezrin, C, Kerenyi, NA. Acidophil stem cell adenoma of the human pituitary. Arch Pathol Lab Med 1977;101:594–599.Google Scholar

Horvath, E, Kovacs, K, Singer, W, et al. Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. Cancer 1981;47:761–771.Google Scholar

Lipper, S, Isenberg, HD, Kahn, LB. Calcospherites in pituitary prolactinomas. A hypothesis for their formation. Arch Pathol Lab Med 1984;108:31–34.Google Scholar

Heitz, PhU, Landolt, AM, Zenklusen, H-R, et al. Immunocytochemistry of pituitary tumors. J Histochem Cytochem 1987;35:1005–1011.Google Scholar

Kovacs, K, Stefaneanu, L, Horvath, E, et al. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat Histopathol 1991;418:439–446.Google Scholar

Asa, SL, Ezzat, S. Medical management of pituitary adenomas: structural and ultrastructural changes. Pituitary 2002;5:133–139.Google Scholar

Tindall, GT, Kovacs, K, Horvath, E, Thorner, MO. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemica, ultrastructural and morphometric study. J Clin Endocrinol Metab 1982;55:1178–1183.Google Scholar

Klibanski, A. Osteoporosis and hyperprolactinemia. Semin Reprod Endocrinol 1984;2:93–98.Google Scholar

Koppelman, MCS, Kurtz, DW, Morrish, KA, et al. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 1984;59:1050–1053.Google Scholar

Gillam, MP, Molitch, ME, Lombardi, G, Colao, A. Advances in the treatment of prolactinomas. Endocr Rev 2006;27:485–534.Google Scholar

Ciric, I, Mikhael, M, Stafford, T, Lawson, L, Garces, R. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 1983;59:395–401.Google Scholar

Domingue, JN, Richmond, IL, Wilson, CB. Results of surgery in 114 patients with prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 1980;137:102–108.Google Scholar

Serri, O, Rasio, E, Beauregard, H, Hardy, J, Somma, M. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 1983;309:280–283.Google Scholar

Laws, ER Jr., Fode, NC, Redmond, MJ. Transsphenoidal surgery following unsuccessful prior therapy: An assessment of benefits and risks in 158 patients. J Neurosurg 1985;63:823–829.Google Scholar

Mehta, AE, Reyes, FI, Faiman, C. Primary radiotherapy of prolactinomas. Eight- to 15-year follow-up. Am J Med 1987;83:49–58.Google Scholar

Moraes, AB, Silva, CM, Vieira, NL, Gadelha, MR. Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf) 2013;79:447–456.Google Scholar

Beck-Peccoz, P, Brucker-Davis, F, Persani, L, Smallridge, RC, Weintraub, BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996;17:610–638.Google Scholar

Hershman, JM, Higgins, HP. Hydatidiform mole: a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator. N Engl J Med 1971;284:573–577.Google Scholar

Gershengorn, MC, Weintraub, BD. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of “inappropriate secretion of TSH.” J Clin Invest 1975;56:633–642.Google Scholar

Kourides, IA, Ridgway, EC, Weintraub, BD, Bigos, ST, Gershengorn, MC, Maloof, F. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab 1977;45:534–543.Google Scholar

Smallridge, RC. Thyrotropin-secreting pituitary tumors. Endocrinol Metab Clin North Am 1987;16:765–792.Google Scholar

Webster, J, Peters, JR, John, R, et al. Pituitary stone: two cases of densely calcified thyrotrophin-secreting pituitary adenomas. Clin Endocrinol (Oxf) 1994;40:137–143.Google Scholar

Horvath, E, Kovacs, K, Smyth, HS, Cusimano, M, Singer, W. Silent adenoma subtype 3 of the pituitary–immunohistochemical and ultrastructural classification: a review of 29 cases. Ultrastruct Pathol 2005;29:511–524.Google Scholar

Erickson, D, Scheithauer, B, Atkinson, J, et al. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience. Clin Endocrinol (Oxf) 2009;71:92–99.Google Scholar

Smallridge, RC, Smith, CE. Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations. Arch Intern Med 1983;143:503–507.Google Scholar

Hill, SA, Falko, JM, Wilson, CB, Hunt, WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg 1982;57:515–519.Google Scholar

Takamatsu, J, Mozai, T, Kuma, K. Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion. J Clin Endocrinol Metab 1984;58:934–936.Google Scholar

Bevan, JS, Burke, CW, Esiri, MM, et al. Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiency. Clin Endocrinol (Oxf) 1989;31:59–70.Google Scholar

Comi, RJ, Gesundheit, N, Murray, L, Gorden, P, Weintraub, BD. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 1987;317:12–17.Google Scholar

Lamberts, SWJ. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 1988;9:417–436.Google Scholar

Orme, SM, Lamb, JT, Nelson, M, Belchetz, PE. Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide. Postgrad Med J 1991;67:466–468.Google Scholar

Snyder, PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985;6:552–563.Google Scholar

Snyder, PJ. Gonadotroph cell pituitary adenomas. Endocrinol Metab Clin North Am 1987;16:755–764.Google Scholar

Jaffe, CA. Clinically non-functioning pituitary adenoma. Pituitary 2006;9:317–321.Google Scholar

Klibanski, A, Deutsch, PJ, Jameson, JL, et al. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. J Clin Endocrinol Metab 1987;64:536–542.Google Scholar

Snyder, PJ, Bashey, HM, Kim, SU, Chappel, SC. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. J Clin Endocrinol Metab 1984;59:1169–1175.Google Scholar

Djerassi, A, Coutifaris, C, West, VA, Asa, SL, Kapoor, SC, Snyder, PJ. Gonadotroph adenoma in a premenopausal woman secreting FSH and causing ovarian hyperstimulation. J Clin Endocrinol Metab 1995;80:591–594.Google Scholar

Cook, DM, Watkins, S, Snyder, PJ. Gonadotrophin-secreting pituitary adenomas masquerading as primary ovarian failure. Clin Endocrinol (Oxf) 1986;25:729–738.Google Scholar

Lamberts, SWJ, Verleun, T, Oosterom, R, et al. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 1987;64:524–530.Google Scholar

Asa, SL, Gerrie, BM, Kovacs, K, et al. Structure-function correlations of human pituitary gonadotroph adenomas in vitro. Lab Invest 1988;58:403–410.Google Scholar

Kwekkeboom, DJ, de Jong, FH, Lamberts, SWJ. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab 1989;68:1128–1135.Google Scholar

Koga, M, Nakao, H, Arao, M, et al. Demonstration of specific dopamine receptors on human pituitary adenomas. Acta Endocrinol (Copenh) 1987;114:595–602.Google Scholar

Lloyd, RV, Anagnostou, D, Chandler, WF. Dopamine receptors in immunohistochemically characterized null cell adenomas and normal human pituitaries. Mod Pathol 1988;1:51–56.Google Scholar

Kwekkeboom, DJ, Hofland, LJ, van Koetsveld, PM, Singh, R, van den Berge, JH, Lamberts, SWJ. Bromocriptine increasingly suppresses the in vitro gonadotropin and a-subunit release from pituitary adenomas during long term culture. J Clin Endocrinol Metab 1990;71:718–724.Google Scholar

Vance, ML, Ridgway, EC, Thorner, MO. Follicle-stimulating hormone- and α-subunit-secreting pituitary tumor treated with bromocriptine. J Clin Endocrinol Metab 1985;61:580–584.Google Scholar

Klibanski, A, Shupnik, MA, Bikkal, HA, Black, PM, Kliman, B, Zervas, NT. Dopaminergic regulation of a-subunit secretion and messenger ribonucleic acid levels in a-secreting pituitary tumors. J Clin Endocrinol Metab 1988;66:96–102.Google Scholar

Bevan, JS, Webster, J, Burke, CW, Scanlon, MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992;13:220–240.Google Scholar

Chanson, P, Brochier, S. Non-functioning pituitary adenomas. J Endocrinol Invest 2005;28(suppl int):93–99.Google Scholar

Vos, P, Croughs, RJM, Thijssen, JHH, van’t Verlaat, JW, van Ginkel, LA. Response of luteinizing hormone secreting pituitary adenoma to a long-acting somatostatin analogue. Acta Endocrinol (Copenh) 1988;118:587–590.Google Scholar

Klibanski, A. Nonsecreting pituitary tumors. Endocrinol Metab Clin North Am 1987;16:793–804.Google Scholar

Horvath, E, Kovacs, K, Killinger, DW, Smyth, HS, Platts, ME, Singer, W. Silent corticotropic adenomas of the human pituitary gland. A histologic, immunocytologic, and ultrastructural study. Am J Pathol 1980;98:617–638.Google Scholar

Scheithauer, BW, Jaap, AJ, Horvath, E, et al. Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 2000;47:723–729.Google Scholar

Lopez, JA, Kleinschmidt-Demasters, BB, Sze, CI, Woodmansee, WW, Lillehei, KO. Silent corticotroph adenomas: further clinical and pathological observations. Hum Pathol 2004;35:1137–1147.Google Scholar

Roncaroli, F, Faustini-Fustini, M, Mauri, F, Asioli, S, Frank, G. Crooke’s hyalinization in silent corticotroph adenoma: report of two cases. Endocr Pathol 2002;13:245–249.Google Scholar

Sakurai, T, Seo, H, Yamamoto, N, et al. Detection of mRNA of prolactin and ACTH in clinically nonfunctioning pituitary adenomas. J Neurosurg 1988;69:653–659.Google Scholar

Lloyd, RV, Fields, K, Jin, L, Horvath, E, Kovacs, K. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization. Am J Pathol 1990;137:479–488.Google Scholar

Trouillas, J, Girod, C, Sassolas, G, et al. A human β-endorphin pituitary adenoma. J Clin Endocrinol Metab 1984;58:242–249.Google Scholar

Asa, SL. Tissue culture in the diagnosis and study of pituitary adenomas. In Lloyd, RV, ed. Surgical Pathology of the Pituitary Gland. Philadelphia, PA: WBSaunders, 1993:94–115.Google Scholar

Chabre, O, Martinie, M, Vivier, J, Eimin-Richard, E, Bertagna, X, Bachelot, I. A clinically silent corticotrophic pituitary adenoma (CSCPA) secreting a biologically inactive but immunoreactive assayable ACTH. J Endocrinol Invest (Milan) 1991;14(suppl 1): 87.Google Scholar

Horvath, E, Kovacs, K. Gonadotroph adenomas of the human pituitary: sex-related fine-structural dichotomy. A histologic, immunocytochemical, and electron-microscopic study of 30 tumors. Am J Pathol 1984;117:429–440.Google Scholar

Sano, T, Kovacs, K, Asa, SL, et al. Pituitary adenoma with “honeycomb Golgi” appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease. Endocr Pathol 2002;13:125–130.Google Scholar

Sano, T, Mader, R, Asa, SL, Qian, ZR, Hino, A, Yamada, S. “Honeycomb Golgi” in pituitary adenomas: not a marker of gonadotroph adenomas. Endocr Pathol 2003;14:363–368.Google Scholar

Kim, K, Yamada, S, Usui, M, Sano, T. Co-localization of honeycomb golgi and ACTH granules in a giant ACTH-producing pituitary adenoma. Endocr Pathol 2005;16:239–244.Google Scholar

Kovacs, K, Lloyd, R, Horvath, E, et al. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 1989;134:345–353.Google Scholar

Tourniaire, J, Trouillas, J, Chalendar, D, Bonneton-Emptoz, A, Goutelle, A, Girod, C. Somatotropic adenoma manifested by galactorrhea without acromegaly. J Clin Endocrinol Metab 1985;61:451–453.Google Scholar

Pagesy, P, Li, JY, Kujas, M, et al. Apparently silent somatotroph adenomas. Pathol Res Pract 1991;187:950–956.Google Scholar

Trouillas, J, Sassolas, G, Loras, B, et al. Somatotropic adenomas without acromegaly. Pathol Res Pract 1991;187:943–949.Google Scholar

Yamada, S, Sano, T, Stefaneanu, L, et al. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. J Clin Endocrinol Metab 1993;76:352–356.Google Scholar

Klibanski, A, Zervas, NT, Kovacs, K, Ridgway, EC. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 1987;66:806–811.Google Scholar

Kalavalapalli, S, Reid, H, Kane, J, Buckler, H, Trainer, P, Heald, AH. Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess. Ann Clin Biochem 2007;44:89–93.Google Scholar

Sidhaye, A, Burger, P, Rigamonti, D, Salvatori, R. Giant somatotrophinoma without acromegalic features: more “quiet” than “silent”: case report. Neurosurgery 2005;56:E1154.Google Scholar

Black, PM, Hsu, DW, Klibanski, A, et al. Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 1987;66:244–250.Google Scholar

Trouillas, J, Girod, C, Sassolas, G, Claustrat, B. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors. Semin Diagn Pathol 1986;3:42–57.Google Scholar

Daneshdoost, L, Gennarelli, TA, Bashey, HM, et al. Recognition of gonadotroph adenomas in women. N Engl J Med 1991;324:589–594.Google Scholar

Asa, SL, Gerrie, BM, Singer, W, Horvath, E, Kovacs, K, Smyth, HS. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986;62:1011–1019.Google Scholar

Jameson, JL, Klibanski, A, Black, PM, et al. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest 1987;80:1472–1478.Google Scholar

Yamada, S, Asa, SL, Kovacs, K. Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison. Virchows Arch A Pathol Anat Histopathol 1988;413:333–339.Google Scholar

Nishioka, H, Mete, O, Asa, SL, et al. The crucial role of pituitary transcription factors in the accurate classification of hormone-negative nonfunctioning pituitary adenomas. In Annual Meeting of the Endocrine Society, 2014.Google Scholar

Komor, J, Reubi, JC, Christ, ER. Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma. Pituitary 2014;17:227–231.Google Scholar

Horn, K, Erhardt, F, Fahlbusch, R, Pickardt, CR, von Werder, K, Scriba, PC. Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor. J Clin Endocrinol Metab 1976;43:137–143.Google Scholar

Duello, TM, Halmi, NS. Pituitary adenoma producing thyrotropin and prolactin. An immunocytochemical and electron microscopic study. Virchows Arch A Pathol Anat Histopathol 1977;376:255–265.Google Scholar

Benoit, R, Pearson-Murphy, BE, Robert, F, et al. Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea. Clin Endocrinol (Oxf) 1980;12:11–19.Google Scholar

Kovacs, K, Horvath, E, Ezrin, C, Weiss, MH. Adenoma of the human pituitary producing growth hormone and thyrotropin. A histologic, immunocytologic and fine-structural study. Virchows Arch A Pathol Anat Histopathol 1982;395:59–68.Google Scholar

Saeger, W, Lüdecke, DK. Pituitary adenomas with hyperfunction of TSH. Frequency, histologic classification, immunocytochemistry and ultrastructure. Virchows Arch A Pathol Anat Histopathol 1982;394:255–267.Google Scholar

Jaquet, P, Hassoun, J, Delori, P, Gunz, G, Grisoli, F, Weintraub, BD. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies. J Clin Endocrinol Metab 1984;59:817–824.Google Scholar

Beck-Peccoz, P, Piscitelli, G, Amr, S, et al. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and a-subunit: evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab 1986;62:704–711.Google Scholar

Trouillas, J, Girod, C, Loras, B, et al. The TSH secretion in the human pituitary adenomas. Pathol Res Pract 1988;183:596–600.Google Scholar

Simard, M, Mirell, CJ, Pekary, AE, Drexler, J, Kovacs, K, Hershman, JM. Hormonal control of thyrotropin and growth hormone secretion in a human thyrotrope pituitary adenoma studied in vitro. Acta Endocrinol (Copenh) 1988;119:283–290.Google Scholar

Malarkey, WB, Kovacs, K, O’Dorisio, TM. Response of a GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules. Neuroendocrinology 1989;49:267–274.Google Scholar

Kuzuya, N, Inoue, K, Ishibashi, M, et al. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, α-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. J Clin Endocrinol Metab 1990;71:1103–1111.Google Scholar

Sherry, SH, Guay, AT, Lee, AK, et al. Concurrent production of adrenocorticotropin and prolactin from two distinct cell lines in a single pituitary adenoma: a detailed immunohistochemical analysis. J Clin Endocrinol Metab 1982;55:947–955.Google Scholar

Sano, T, Kovacs, K, Asa, SL, Smyth, HS. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Virchows Arch A Pathol Anat Histopathol 1990;417:361–367.Google Scholar

Cunningham, GR, An, Huckins C. FSH and prolactin-secreting pituitary tumor: Pituitary dynamics and testicular histology. J Clin Endocrinol Metab 1977;44:248–253.Google Scholar

Faggiano, M, Criscuolo, T, Perrone, L, Quarto, C, Sinisi, AA. Sexual precocity in a boy due to hypersecretion of LH and prolactin by a pituitary adenoma. Acta Endocrinol (Copenh) 1983;102:167–172.Google Scholar

Koide, Y, Kugai, N, Kimura, S, et al. A case of pituitary adenoma with possible simultaneous secretion of thyrotropin and follicle-stimulating hormone. J Clin Endocrinol Metab 1982;54:397–403.Google Scholar

Berg, KK, Scheithauer, BW, Felix, I, et al. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases. Neurosurgery 1990;26:397–403.Google Scholar

Alexander, JM, Biller, BMK, Bikkal, H, Zervas, NT, Arnold, A, Klibanski, A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 1990;86:336–340.Google Scholar

Herman, V, Fagin, J, Gonsky, R, Kovacs, K, Melmed, S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71:1427–1433.Google Scholar

Schulte, HM, Oldfield, EH, Allolio, B, Katz, DA, Berkman, RA, Ali, IU. Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 1991;73:1302–1308.Google Scholar

Wermer, P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;16:363–371.Google Scholar

Scheithauer, BW, Laws, ER Jr., Kovacs, K, Horvath, E, Randall, RV, Carney, JA. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 1987;4:205–211.Google Scholar

Chandrasekharappa, SC, Guru, SC, Manickam, P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404–407.Google Scholar

Dong, Q, Debelenko, LV, Chandrasekharappa, SC, et al. Loss of heterozygosity at 11p13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997;82:1416–1420.Google Scholar

Zhuang, Z, Ezzat, S, Vortmeyer, AO, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 1997;57:5446–5451.Google Scholar

Asa, SL, Somers, K, Ezzat, S. The MEN1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 1998;83:3210–3212.Google Scholar

Pellegata, NS, Quintanilla-Martinez, L, Siggelkow, H, et al. Germ-line mutations in p27^Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006;103:15558–15563.Google Scholar

Georgitsi, M, Raitila, A, Karhu, A, et al. Germline CDKN1B/p27^Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007;92:3321–3325.Google Scholar

Agarwal, SK, Mateo, CM, Marx, SJ. Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 2009;94:1826–1834.Google Scholar

Kirschner, LS, Carney, JA, Pack, SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89–92.Google Scholar

Yin, Z, Williams-Simons, L, Parlow, AF, Asa, S, Kirschner, LS. Pituitary-specific knockout of the Carney complex gene prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 2008;22:380–387.Google Scholar

Carney, JA, Gordon, H, Carpenter, PC, Shenoy, BV, Go, VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270–283.Google Scholar

Kaltsas, GA, Kola, B, Borboli, N, et al. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 2002;57:443–448.Google Scholar

Sandrini, F, Kirschner, LS, Bei, T, et al. PRKAR1A, one of the Carney complex genes, and its locus (17q22–24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 2002;39:e78.Google Scholar

Soares, BS, Frohman, LA. Isolated familial somatotropinoma. Pituitary 2004;7:95–101.Google Scholar

Beckers, A, Daly, AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007;157:371–382.Google Scholar

Vierimaa, O, Georgitsi, M, Lehtonen, R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312:1228–1230.Google Scholar

Georgitsi, M, De Menis, E, Cannavò, S, et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf) 2008;69:621–627.Google Scholar

DiGiovanni, R, Serra, S, Ezzat, S, Asa, SL. AIP mutations are not identified in patients with sporadic pituitary adenomas. Endocr Pathol 2007;18:76–78.Google Scholar

Papathomas, TG, Gaal, J, Corssmit, EP, et al. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC–PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol 2014;170:1–12.Google Scholar

Gill, AJ, Toon, CW, Clarkson, A, et al. Succinate dehydrogenase deficiency is rare in pituitary adenomas. Am J Surg Pathol 2014;38:560–566.Google Scholar

Asa, SL, Ezzat, S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002;2:836–849.Google Scholar

Ezzat, S, Asa, SL. Mechanisms of disease: the pathogenesis of pituitary tumors. Nat Clin Pract Endocrinol Metab 2006;2:220–230.Google Scholar

Asa, SL, Ezzat, S. The pathogenesis of pituitary tumors. Annu Rev Pathol 2009;4:97–126.Google Scholar

Vallar, L, Spada, A, Giannattasio, G. Altered G_s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987;330:566–568.Google Scholar

Landis, CA, Masters, SB, Spada, A, Pace, AM, Bourne, HR, Vallar, L. GTPase inhibiting mutations activate the alpha-chain of Gs and stimulate adenylate cyclase in human pituitary tumors. Nature 1989;340:692–696.Google Scholar

Hayward, BE, Barlier, A, Korbonits, M, et al. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001;107:R31–R36.Google Scholar

Itoh, N, Ornitz, DM. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004;20:563–569.Google Scholar

Ezzat, S, Walpola, IA, Ramyar, L, Smyth, HS, Asa, SL. Membrane-anchored expression of transforming growth factor-a in human pituitary adenoma cells. J Clin Endocrinol Metab 1995;80:534–539.Google Scholar

McAndrew, J, Paterson, AJ, Asa, SL, McCarthy, KJ, Kudlow, JE. Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 1995;136:4479–4488.Google Scholar

LeRiche, V, Asa, SL, Ezzat, S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 1996;81:656–662.Google Scholar

Ezzat, S, Zheng, L, Smyth, HS, Asa, SL. The c-erbB-2/neu proto-oncogene in human pituitary tumours. Clin Endocrinol (Oxf) 1997;46:599–606.Google Scholar

Cooper, O, Vlotides, G, Fukuoka, H, Greene, MI, Melmed, S. Expression and function of ErbB receptors and ligands in the pituitary. Endocr Relat Cancer 2011;18:R197–R211.Google Scholar

Haddad, G, Penabad, JL, Bashey, HM, et al. Expression of activin/inhibin subunit messenger ribonucleic acids by gonadotroph adenomas. J Clin Endocrinol Metab 1994;79:1399–1403.Google Scholar

Penabad, JL, Bashey, HM, Asa, SL, et al. Decreased follistatin gene expression in gonadotroph adenomas. J Clin Endocrinol Metab 1996;81:3397–3403.Google Scholar

Abbass, SAA, Asa, SL, Ezzat, S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1160–1166.Google Scholar

Zhu, X, Asa, SL, Ezzat, S. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia. Clin Cancer Res 2008;14:1984–1996.Google Scholar

Zhu, X, Lee, K, Asa, SL, Ezzat, S. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells. Am J Pathol 2007;170:1618–1628.Google Scholar

Qian, ZK, Sano, T, Asa, SL, et al. Cytoplasmic expression of fibroblast growth factor receptor‐4 (ptd‐FGFR4) in human pituitary adenomas. J Clin Endocrinol Metab 2004;89:1904–1911.Google Scholar

Ezzat, S, Yu, S, Asa, SL. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5′ fibroblast growth factor receptor-4 promoter. Am J Pathol 2003;163:1177–1184.Google Scholar

Yu, S, Asa, SL, Weigel, RJ, Ezzat, S. Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4. J Biol Chem 2003;278:19597–19602.Google Scholar

Ezzat, S, Zheng, L, Asa, SL. Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia. Mol Endocrinol 2004;18:2543–2552.Google Scholar

Daniel, L, Trouillas, J, Renaud, W, et al. Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy. Cancer Res 2000;60:80–85.Google Scholar

Zhu, X, Mao, X, Hurren, R, Schimmer, AD, Ezzat, S, Asa, SL. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. J Clin Endocrinol Metab 2008;93:3610–3617.Google Scholar

Liu, W, Asa, SL, Ezzat, S. Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Brain Pathol 2002;12:412–419.Google Scholar

Amaral, FC, Torres, N, Saggioro, F, et al. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 2009;94:320–323.Google Scholar

Bellodi, C, Krasnykh, O, Haynes, N, et al. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res 2010;70:6026–6035.Google Scholar

Ezzat, S, Zhu, X, Loeper, S, Fischer, S, Asa, SL. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells. Mol Endocrinol 2006;20:2976–2986.Google Scholar

Loeper, S, Asa, SL, Ezzat, S. Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation. Cancer Res 2008;68:3715–3723.Google Scholar

Fedele, M, Battista, S, Kenyon, L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002;21:3190–3198.Google Scholar

Fedele, M, Pentimalli, F, Baldassarre, G, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005;24:3427–3435.Google Scholar

De, M, I, Visone, R, Wierinckx, A, et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res 2009;69:1844–1850.Google Scholar

Finelli, P, Pierantoni, GM, Giardino, D, et al. The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 2002;62:2398–2405.Google Scholar

Evans, CO, Moreno, CS, Zhan, X, et al. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary 2008;11:231–245.Google Scholar

Qian, ZR, Asa, SL, Siomi, H, et al. Overexpression of HMGA2 relates to reduction of the Let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol 2009;22:431–441.Google Scholar

Muller, HL. Craniopharyngioma. Endocr Rev 2014;35:513–543.Google Scholar

Banna, M. Cranopharyngioma: based on 160 cases. Br J Radiol 1976;49:206–223.Google Scholar

Petito, CK, DeGirolami, U, Earle, KM. Craniopharyngiomas. A clinical and pathological review. Cancer 1976;37:1944–1952.Google Scholar

Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon: International Agency for Research on Cancer, 2007.Google Scholar

Scheithauer, BW. The hypothalamus and neurohypophysis. In Kovacs, K, Asa, SL, eds. Functional Endocrine Pathology. Boston: Blackwell Scientific, 1998:171–246.Google Scholar

Azar-Kia, B, Krishnan, UR, Schechter, MM. Neonatal craniopharyngioma. Case report. J Neurosurg 1975;42:91–93.Google Scholar

Lederman, GS, Recht, A, Loeffler, JS, Dubuisson, D, Kleefield, J, Schnitt, SJ. Craniopharyngioma in an elderly patient. Cancer 1987;60:1077–1080.Google Scholar

Lewin, R, Ruffolo, E, Saraceno, C. Craniopharyngioma arising in the pharyngeal hypophysis. Southern Med J 1984;77:1519–1523.Google Scholar

Koral, K, Weprin, B, Rollins, NK. Sphenoid sinus craniopharyngioma simulating mucocele. Acta Radiol 2006;47:494–496.Google Scholar

Baskin, DS, Wilson, CB. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 1986;65:22–27.Google Scholar

Brown, JL, Burton, DW, Deftos, LJ, Smith, AA, Pincus, DW, Haller, MJ. Congenital craniopharyngioma and hypercalcemia induced by parathyroid hormone-related protein. Endocr Pract 2007;13:67–71.Google Scholar

Cusimano, MD, Kovacs, K, Bilbao, JM, Tucker, WS, Singer, W. Suprasellar craniopharyngioma associated with hyperprolactinemia, pituitary lactotroph hyperplasia, and microprolactinoma. Case report. J Neurosurg 1988;69:620–623.Google Scholar

Wheatley, T, Clark, JDA, Stewart, S. Craniopharyngioma with hyperprolactinaemia due to a prolactinoma. J Neurol Neurosurg Psychiatry 1986;49:1305–1307.Google Scholar

Yoshida, A, Sen, C, Asa, SL, Rosenblum, MK. Composite pituitary adenoma and craniopharyngioma? An unusual sellar neoplasm with divergent differentiation. Am J Surg Pathol 2008;32:1736–1741.Google Scholar

Moshkin, O, Scheithauer, BW, Syro, LV, Velasquez, A, Horvath, E, Kovacs, K. Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report. Endocr Pathol 2009;20:50–55.Google Scholar

Gokden, M, Mrak, RE. Pituitary adenoma with craniopharyngioma component. Hum Pathol 2009;40:1189–1193.Google Scholar

Puchner, MJA, Lüdecke, DK, Saeger, W. The anterior pituitary lobe in patients with cystic craniopharyngiomas: three cases of associated lymphocytic hypophysitis. Acta Neurochir 1994;126:38–43.Google Scholar

Xin, W, Rubin, MA, McKeever, PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 2002;126:1174–1178.Google Scholar

Rickert, CH, Paulus, W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J Neurol Neurosurg Psychiatry 2003;74:260–261.Google Scholar

Rienstein, S, Adams, EF, Pilzer, D, Goldring, AA, Goldman, B, Friedman, E. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 2003;98:162–164.Google Scholar

Sekine, S, Shibata, T, Kokubu, A, et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 2002;161:1997–2001.Google Scholar

Buslei, R, Nolde, M, Hofmann, B, et al. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005;109:589–597.Google Scholar

Oikonomou, E, Barreto, DC, Soares, B, De Marco, L, Buchfelder, M, Adams, EF. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 2005;73:205–209.Google Scholar

Brastianos, PK, Taylor-Weiner, A, Manley, PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 2014;46:161–165.Google Scholar

Park, YS, Ahn, JY, Kim, DS, Kim, TS, Kim, SH. Late development of craniopharyngioma following surgery for Rathke’s cleft cyst. Clin Neuropathol 2009;28:177–181.Google Scholar

Link, MJ, Driscoll, CL, Giannini, C. Isolated, giant cerebellopontine angle craniopharyngioma in a patient with Gardner syndrome: case report. Neurosurgery 2002;51:221–225.Google Scholar

Sarubi, JC, Bei, H, Adams, EF, et al. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. Neurosci Lett 2001;310:5–8.Google Scholar

Boch, AL, van Effenterre, R, Kujas, M. Craniopharyngiomas in two consanguineous siblings: case report. Neurosurgery 1997;41:1185–1187.Google Scholar

Laws, ER Jr. Craniopharyngioma: diagnosis and treatment. Endocrinologist 1992;2:184–188.Google Scholar

Minniti, G, Esposito, V, Amichetti, M, Enrici, RM. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev 2009;32:125–132.Google Scholar

Gopalan, R, Dassoulas, K, Rainey, J, Sherman, JH, Sheehan, JP. Evaluation of the role of gamma knife surgery in the treatment of craniopharyngiomas. Neurosurg Focus 2008;24:E5.Google Scholar

Scheithauer, BW, Kovacs, K, Horvath, E, et al. Pituitary blastoma. Acta Neuropathol 2008;116:657–666.Google Scholar

Scheithauer, BW, Horvath, E, Abel, TW, et al. Pituitary blastoma: a unique embryonal tumor. Pituitary 2012;15:365–373.Google Scholar

Doros, L, Schultz, KA, Stewart, DR, et al. DICER-1 related disorders. In Pagon, RA, Adam, MP, Bird, TD, Dolan, CR, Fong, CT, Stephens, K eds. GeneReviews. Seattle, WA: University of Washington, 2014 (http://www.ncbi.nlm.nih.gov/books/NBK196157/, accessed 10 September 2015).Google Scholar

de Kock, L, Sabbaghian, N, Plourde, F, et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 2014;128:111–122.Google Scholar

Puchner, MJA, Lüdecke, DK, Saeger, W, Riedel, M, Asa, SL. Gangliocytomas of the sellar region: a review. Exper Clin Endocrinol 1995;103:129–149.Google Scholar

Rhodes, RH, Dusseau, JJ, Boyd, AS, Knigge, KM. Intrasellar neural-adenohypophyseal choristoma. a morphological and immunocytochemical study. J Neuropathol Exp Neurol 1982;41:267–280.Google Scholar

Scheithauer, BW, Kovacs, K, Randall, RV, Horvath, E, Okazaki, H, Laws, ER Jr. Hypothalamic neuronal hamartoma and adenohypophyseal neuronal choristoma: Their association with growth hormone adenoma of the pituitary gland. J Neuropathol Exp Neurol 1983;42:648–663.Google Scholar

Felix, I, Bilbao, JM, Asa, SL, Tyndel, F, Kovacs, K, Becker, LE. Cerebral and cerebellar gangliocytomas: a morphological study of nine cases. Acta Neuropathol (Berl) 1994;88:246–251.Google Scholar

Hall, JG, Pallister, PD, Clarren, SK, et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly–a new syndrome? Part I: clinical, causal, and pathogenetic considerations. Am J Med Genet 1980;7:47–74.Google Scholar

Kang, S, Graham, JM Jr., Olney, AH, Biesecker, LG. GLI3 frameshift mutations cause autosomal dominant Pallister–Hall syndrome. Nat Genet 1997;15:266–268.Google Scholar

Johnston, JJ, Olivos-Glander, I, Killoran, C, et al. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister–Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet 2005;76:609–622.Google Scholar

Kontogeorgos, G, Mourouti, G, Kyrodimou, E, Liapi-Avgeri, G, Parasi, E. Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells. Acta Neuropathol 2006;112:21–28.Google Scholar

Bevan, JS, Asa, SL, Rossi, ML, Esiri, MM, Adams, CBT, Burke, CW. Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf) 1989;30:213–224.Google Scholar

Li, JY, Racadot, O, Kujas, M, Kouadri, M, Peillon, F, Racadot, J. Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea , Cushing’s disease and isolated tumoral syndrome. Acta Neuropathol (Berl) 1989;77:320–328.Google Scholar

Slowik, F, Fazekas, I, Bálint, K, et al. Intrasellar hamartoma associated with pituitary adenoma. Acta Neuropathol (Berl) 1990;80:328–333.Google Scholar

Matsuno, A, Nagashima, T. Prolactin-secreting gangliocytoma. J Neurosurg 2001;95:167–168.Google Scholar

Serri, O, Berthelet, F, Belair, M, Vallette, S, Asa, SL. An unusual association of a sellar gangliocytoma with a prolactinoma. Pituitary 2008;11:85–87.Google Scholar

Judge, DM, Kulin, HE, Page, R, Santen, R, Trapukdi, S. Hypothalamic hamartoma. A source of luteinizing-hormone-releasing factor in precoucious puberty. N Engl J Med 1977;296:7–10.Google Scholar

Hochman, HI, Judge, DM, Reichlin, S. Precocious puberty and hypothalamic hamartoma. Pediatrics 1981;67:236–244.Google Scholar

Culler, FL, James, HE, Simon, ML, Jones, KL. Identification of gonadotropin-releasing hormone in neurons of a hypothalamic hamartoma in a boy with precocious puberty. Neurosurgery 1985;17:408–417.Google Scholar

Nishio, S, Fujiwara, S, Aiko, Y, Takeshita, I, Fukui, M. Hypothalamic hamartoma. Report of two cases. J Neurosurg 1989;70:640–645.Google Scholar

Yamada, S, Stefaneanu, L, Kovacs, K, Aiba, T, Shishiba, Y, Hara, M. Intrasellar gangliocytoma with multiple immunoreactivities. Endocr Pathol 1990;1:58–63.Google Scholar

Asa, SL, Bilbao, JM, Kovacs, K, Linfoot, JA. Hypothalamic neuronal hamartoma associated with pituitary growth hormone cell adenoma and acromegaly. Acta Neuropathol (Berl) 1980;52:231–234.Google Scholar

Horvath, E, Kovacs, K, Tran, A, Scheithauer, BW. Ganglion cells in the posterior pituitary: result of ectopia or transdifferentiation? Acta Neuropathol 2000;100:106–110.Google Scholar

Geddes, JF, Jansen, GH, Robinson, SF, et al. “Gangliocytomas” of the pituitary: a heterogeneous group of lesions with differing histogenesis. Am J Surg Pathol 2000;24:607–613.Google Scholar

Romanelli, P, Muacevic, A, Striano, S. Radiosurgery for hypothalamic hamartomas. Neurosurg Focus 2008;24:E9.Google Scholar

Hassoun, J, Gambarelli, D, Grisoli, F, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 1982;56:151–156.Google Scholar

Yang, GF, Wu, SY, Zhang, LJ, Lu, GM, Tian, W, Shah, K. Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature. AJNR Am J Neuroradiol 2009;30:581–585.Google Scholar

Maguire, JA, Bilbao, JM, Kovacs, K, Resch, L. Hypothalamic neurocytoma with vasopressin immunoreactivity: immunohistochemical and ultrastructural observations. Endocr Pathol 1992;3:99–104.Google Scholar

Araki, Y, Sakai, N, Andoh, T, Yoshimura, S, Yamada, H. Central neurocytoma presenting with gigantism: case report. Surg Neurol 1992;38:141–145.Google Scholar

Soylemezoglu, F, Scheithauer, BW, Esteve, J, Kleihues, P. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997;56:551–556.Google Scholar

Rades, D, Schild, SE, Fehlauer, F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 2004;62:987–989.Google Scholar

Myung, JK, Cho, HJ, Park, CK, et al. Clinicopathological and genetic characteristics of extraventricular neurocytomas. Neuropathology 2013;33:111–121.Google Scholar

Rades, D, Fehlauer, F, Schild, SE. Treatment of atypical neurocytomas. Cancer 2004;100:814–817.Google Scholar

Steel, TR, Dailey, AT, Born, D, Berger, MS, Mayberg, MR. Paragangliomas of the sellar region: report of two cases. Neurosurgery 1993;32:844–847.Google Scholar

Mokry, M, Kleinert, R, Clarici, G, Obermayer-Pietsch, B. Primary paraganglioma simulating pituitary macroadenoma: a case report and review of the literature. Neuroradiology 1998;40:233–237.Google Scholar

Sambaziotis, D, Kontogeorgos, G, Kovacs, K, Horvath, E, Levedis, A. Intrasellar paraganglioma presenting as nonfunctioning pituitary adenoma. Arch Pathol Lab Med 1999;123:429–432.Google Scholar

Naggara, O, Varlet, P, Page, P, Oppenheim, C, Meder, JF. Suprasellar paraganglioma: a case report and review of the literature. Neuroradiology 2005;47:753–757.Google Scholar

Boari, N, Losa, M, Mortini, P, Snider, S, Terreni, MR, Giovanelli, M. Intrasellar paraganglioma: a case report and review of the literature. Acta Neurochir (Wien) 2006;148:1311–1314.Google Scholar

Sinha, S, Sharma, MC, Sharma, BS. Malignant paraganglioma of the sellar region mimicking a pituitary macroadenoma. J Clin Neurosci 2008;15:937–939.Google Scholar

Haresh, KP, Prabhakar, R, Anand Rajan, KD, Sharma, DN, Julka, PK, Rath, GK. A rare case of paraganglioma of the sella with bone metastases. Pituitary 2009;12:276–279.Google Scholar

Scheithauer, BW, Parameswaran, A, Burdick, B. Intrasellar paraganglioma: report of a case in a sibship of von Hippel–Lindau disease. Neurosurgery 1996;38:395–399.Google Scholar

Erlic, Z, Neumann, HP. Diagnosing patients with hereditary paraganglial tumours. Lancet Oncol 2009;10:741.Google Scholar

Dahia, PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 2014;14:108–119.Google Scholar

Brat, DJ, Scheithauer, BW, Staugaitis, SM, Holtzman, RN, Morgello, S, Burger, PC. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol 2000;24:362–368.Google Scholar

Roncaroli, F, Scheithauer, BW, Cenacchi, G, et al. ‘Spindle cell oncocytoma’ of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol 2002;26:1048–1055.Google Scholar

Dahiya, S, Sarkar, C, Hedley-Whyte, ET, et al. Spindle cell oncocytoma of the adenohypophysis: report of two cases. Acta Neuropathol (Berl) 2005;110:97–99.Google Scholar

Kloub, O, Perry, A, Tu, PH, Lipper, M, Lopes, MB. Spindle cell oncocytoma of the adenohypophysis: report of two recurrent cases. Am J Surg Pathol 2005;29:247–253.Google Scholar

Vajtai, I, Sahli, R, Kappeler, A. Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up. Pathol Res Pract 2006;202:745–750.CrossRef Google Scholar PubMed

Shanklin, WM. The origin, histology and senescence of tumorettes in the human neurohypophysis. Acta Anat (Basel) 1953;18:1–20.Google Scholar

Luse, SA, Kernohan, JW. Granular cell tumors of the stalk and posterior lobe of the pituitary gland. Cancer 1955;8:616–622.Google Scholar

Kamil, Z, Sinson, S, Gucer, H, Asa, SL, Mete, O. TTF-1-expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma. Endocr Pathol 2013;25:436–438.Google Scholar

Policarpio-Nicolas, ML, Le, BH, Mandell, JW, Lopes, MB. Granular cell tumor of the neurohypophysis: report of a case with intraoperative cytologic diagnosis. Diagn Cytopathol 2008;36:58–63.Google Scholar

Vaquero, J, Leunda, G, Cabezudo, JM, Salazar, AR, de Miguel, J. Granular pituicytomas of the pituitary stalk. Acta Neurochir 1981;59:209–215.Google Scholar

Tomita, T, Kuziez, M, Watanabe, I. Double tumors of the anterior and posterior pituitary gland. Acta Neuropathol (Berl) 1981;54:161–164.Google Scholar

Tuch, BE, Carter, JN, Armellin, GM, Newland, RC. The association of a tumour of the posterior pituitary gland with multiple endocrine neoplasia type I. Aust NZ J Med 1982;12:179–181.Google Scholar

Iglesias, A, Arias, M, Brasa, J, Paramo, C, Conde, C, Fernandez, R. MR imaging findings in granular cell tumor of the neurohypophysis: a difficult preoperative diagnosis. Eur Radiol 2000;10:1871–1873.Google Scholar

Borota, OC, Scheithauer, BW, Fougner, SL, Hald, JK, Ramm-Pettersen, J, Bollerslev, J. Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment. Clin Neuropathol 2009;28:91–95.CrossRef Google Scholar PubMed

Coire, CI, Horvath, E, Smyth, HS, Kovacs, K. Rapidly recurring folliculostellate cell tumor of the adenohypophysis with the morphology of a spindle cell oncocytoma: case report with electron microscopic studies. Clin Neuropathol 2009;28:303–308.Google Scholar

Ulrich, J, Heitz, PhU, Fischer, T, Obrist, E, Gullotta, F. Granular cell tumors: evidence for heterogeneous tumor cell differentiation. An immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 1987;53:52–57.CrossRef Google Scholar PubMed

Rodriguez, FJ, Scheithauer, BW, Roncaroli, F, et al. Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study. Am J Surg Pathol 2008;32:1344–1352.Google Scholar

Nishioka, H, Ii, K, Llena, JF, Hirano, A. Immunohistochemical study of granular cell tumors of the neurohypophysis. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:413–417.Google Scholar

Landolt, AM. Granular cell tumors of the neurohypophysis. Acta Neurochir Suppl 1975;22:120–128.Google Scholar

Rossi, ML, Bevan, JS, Esiri, MM, Hughes, JT, Adams, CBT. Pituicytoma (pilocytic astrocytoma). J Neurosurg 1987;67:768–772.Google Scholar

Winer, JB, Lidov, H, Scaravilli, F. An ependymoma involving the pituitary fossa. J Neurol Neurosurg Psychiatry 1989;52:1443–1444.Google Scholar

Scheithauer, BW, Swearingen, B, Whyte, ET, Auluck, PK, Stemmer-Rachamimov, AO. Ependymoma of the sella turcica: a variant of pituicytoma. Hum Pathol 2009;40:435–440.Google Scholar

Huang, C-I, Chiou, W-H, Ho, DM. Oligodendroglioma occurring after radiation therapy for pituitary adenoma. J Neurol Neurosurg Psychiatry 1987;50:1619–1624.Google Scholar

Wong, JYC, Uhl, V, Wara, WM, Sheline, GE. Optic gliomas. a reanalysis of the University of California, San Francisco experience. Cancer 1987;60:1847–1855.Google Scholar

Rush, JA, Younge, BR, Campbell, RJ, MacCarty, CS. Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 1982;89:1213–1219.Google Scholar

Alvord, EC Jr., Lofton, S. Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J Neurosurg 1988;68:85–98.Google Scholar

Riccardi, VM. Neurofibromatosis. In Gomez, MR, ed. Neurocutaneous Syndromes: A Practical Approach. Boston: Butterworths, 1987:11–29.Google Scholar

Weinstein, JM, Backonja, M, Houston, LW, et al. Optic glioma associated with Beckwith–Wiedemann syndrome. Pediatr Neurol 1986;2:308–310.Google Scholar

Liwnicz, BH, Berger, TS, Liwnicz, RG, Aron, BS. Radiation-associated gliomas: a report of four cases and analysis of postradiation tumors of the central nervous system. Neurosurgery 1985;17:436–445.Google Scholar

Hufnagel, TJ, Kim, JH, Lesser, R, et al. Malignant glioma of the optic chiasm eight years after radiotherapy for prolactinoma. Arch Ophthalmol 1988;106:1701–1705.Google Scholar

Dierssen, G, Figols, J, Trigueros, F, Alvarez, G. Gliomas astrocitarios asociados a radioterapia previa. Arch Neurobiol 1987;50:303–308.Google Scholar

Marus, G, Levin, CV, Rutherfoord, GS. Malignant glioma following radiotherapy for unrelated primary tumors. Cancer 1986;58:886–894.Google Scholar

Okamoto, S, Handa, H, Yamashita, J, Tokuriki, Y, Abe, M. Post-irradiation brain tumors. Neurol Med Chir 1985;25:528–533.Google Scholar

Piatt, JH, Blue, JM, Schold, SC, Burger, PC. Glioblastoma multiforme after radiotherapy for acromegaly. Neurosurgery 1983;13:85–89.Google Scholar

Zampieri, P, Zorat, PL, Mingrino, S, Soattin, GB. Radiation-associated cerebral gliomas. A report of two cases and review of the literature. J Neursurg Sci 1989;33:271–279.Google Scholar

Kitanaka, C, Shitara, N, Nakagomi, T, et al. Postradiation astrocytoma. Report of two cases. J Neurosurg 1989;70:469–474.CrossRef Google Scholar PubMed

Ushio, Y, Arita, N, Yoshimine, T, Nagatani, M, Mogami, H. Glioblastoma after radiotherapy for craniopharyngioma: case report. Neurosurgery 1987;21:33–38.CrossRef Google Scholar PubMed

Maat-Schieman, MLC, Bots, GTAM, Thomeer, RTWM, Vielvoye, GJ. Malignant astrocytoma following radiotherapy for craniopharyngioma. Br J Radiol 1985;58:480–482.Google Scholar

Okamoto, S, Handa, H, Yamashita, J, Tokuriki, Y, Abe, M. Post-irradiation brain tumors. Neurol Med Chir 1985;25:528–533.Google Scholar

Tibbetts, KM, Emnett, RJ, Gao, F, Perry, A, Gutmann, DH, Leonard, JR. Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathol 2009;117:657–665.Google Scholar

Horbinski, C, Hamilton, RL, Lovell, C, Burnham, J, Pollack, IF. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas. Brain Pathol 2010;20:581–583.Google Scholar

Rodriguez, FJ, Scheithauer, BW, Burger, PC, Jenkins, S, Giannini, C. Anaplasia in pilocytic astrocytoma predicts aggressive behavior. Am J Surg Pathol 2010;34:147–160.Google Scholar

Pfister, S, Janzarik, WG, Remke, M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 2008;118:1739–1749.CrossRef Google Scholar PubMed

Jones, DT, Kocialkowski, S, Liu, L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008;68:8673–8677.Google Scholar

Jones, DT, Kocialkowski, S, Liu, L, Pearson, DM, Ichimura, K, Collins, VP. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009;28:2119–2123.Google Scholar

Janzarik, WG, Kratz, CP, Loges, NT, et al. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics 2007;38:61–63.Google Scholar

Tchoghandjian, A, Fernandez, C, Colin, C, et al. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature. Brain 2009;132:1523–1535.Google Scholar

Rohringer, M, Sutherland, GR, Louw, DF, Sima, AAF. Incidence and clinicopathological features of meningioma. J Neurosurg 1989;71:665–672.Google Scholar

Sridhar, K, Ramamurthi, B. Intracranial meningioma subsequent to radiation for a pituitary tumor: case report. Neurosurgery 1989;25:643–645.Google Scholar

Kasantikul, V, Shuangshoti, S, Phonprasert, C. Intrasellar meningioma after radiotherapy for prolactinoma. J Med Assoc Thai 1988;71:524–527.Google Scholar

Spallone, A. Meningioma as a sequel of radiotherapy for pituitary adenoma. Neurochirurgia 1982;25:68–72.Google Scholar

Yeakley, JW, Kulkarni, MV, McArdle, CB, Haar, FL, Tang, RA. High-resolution MR imaging of juxtasellar meningiomas with CT and angiographic correlation. AJNR Am J Neuroradiol 1988;9:279–285.Google Scholar

Michael, AS, Paige, ML. MR imaging of intrasellar meningiomas simulating pituitary adenomas. J Comput Assist Tomogr 1988;12:944–946.Google Scholar

Slavin, MJ, Weintraub, J. Suprasellar meningioma with intrasellar extension simulating pituitary adenoma. Arch Ophthalmol 1987;105:1488–1489.Google Scholar

Halper, J, Colvard, DS, Scheithauer, BW, et al. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Neurosurgery 1989;25:546–553.Google Scholar

Probst, Ch. Possibilities and limitations of microsurgery in patients with meningiomas of the sellar region. Acta Neurochir 1987;84:99–102.Google Scholar

Ishige, N, Ito, C, Saeki, N, Oka, N. Neurinoma with intrasellar extension: a case report. Neurol Surg 1985;13:79–84.Google Scholar

Wilberger, JE Jr. Primary intrasellar schwannoma: case report. Surg Neurol 1989;32:156–158.Google Scholar

Perone, TP, Robinson, B, Holmes, SM. Intrasellar schwannoma: case report. Neurosurgery 1984;14:71–73.CrossRef Google Scholar PubMed

Maartens, NF, Ellegala, DB, Vance, ML, Lopes, MB, Laws, ER Jr. Intrasellar schwannomas: report of two cases. Neurosurgery 2003;52:1200–1205.Google Scholar

Honegger, J, Koerbel, A, Psaras, T, Petrick, M, Mueller, K. Primary intrasellar schwannoma: clinical, aetiopathological and surgical considerations. Br J Neurosurg 2005;19:432–438.Google Scholar

Perez, MT, Farkas, J, Padron, S, Changus, JE, Webster, EL. Intrasellar and parasellar cellular schwannoma. Ann Diagn Pathol 2004;8:142–150.Google Scholar

Pernicone, PJ, Scheithauer, B, Sebo, TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 1997;79:804–812.Google Scholar

Petterson, T, MacFarlane, IA, MacKenzie, JM, Shaw, MDM. Prolactin secreting pituitary carcinoma. J Neurol Neurosurg Psychiatry 1992;55:1205–1206.Google Scholar

Walker, JD, Grossman, A, Anderson, JV, et al. Malignant prolactinoma with extracranial metastases: a report of three cases. Clin Endocrinol (Oxf) 1993;38:411–419.Google Scholar

Saeger, W, Lüdecke, DK. Pituitary carcinomas. Endocr Pathol 1996;7:21–35.Google Scholar

Brown, RL, Muzzafar, T, Wollman, R, Weiss, RE. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol 2006;154:639–643.Google Scholar

Guastamacchia, E, Triggiani, V, Tafaro, E, et al. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report. Minerva Endocrinol 2007;32:231–236.Google Scholar

Frost, AR, Tenner, S, Tenner, M, Rollhauser, C, Tabbara, SO. ACTH-producing pituitary carcinoma presenting as the cauda equina syndrome. Arch Pathol Lab Med 1995;119:93–96.Google Scholar

Kouhara, H, Tatekawa, T, Koga, M, et al. Intracranial and intraspinal dissemination of an ACTH-secreting pituitary tumor. Endocrinol Jpn 1992;39:177–184.Google Scholar

Pinchot, SN, Sippel, R, Chen, H. ACTH-producing carcinoma of the pituitary with refractory Cushing’s disease and hepatic metastases: a case report and review of the literature. World J Surg Oncol 2009;7:39.Google Scholar

Zahedi, A, Booth, GL, Smyth, HS, et al. Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma. Clin Endocrinol (Oxf) 2001;55:549–556.Google Scholar

Stewart, PM, Carey, MP, Graham, CT, Wright, AD, London, DR. Growth hormone secreting pituitary carcinoma: a case report and literature review. Clin Endocrinol (Oxf) 1992;37:189–195.Google Scholar

Mixson, AJ, Friedman, TC, Katz, DA, et al. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 1993;76:529–533.Google Scholar

Luzi, P, Miracco, C, Lio, R, et al. Endocrine inactive pituitary carcinoma metastasizing to cervical lymph nodes: a case report. Hum Pathol 1987;18:90–92.Google Scholar

Kuroki, M, Tanaka, r, Yokoyama, M, Shimbo, Y, Ikuta, F. Subarachnoid dissemination of a pituitary adenoma. Surg Neurol 1987;28:71–76.Google Scholar

Roncaroli, F, Scheithauer, BW, Horvath, E, et al. Silent subtype 3 carcinoma of the pituitary: a case report. Neuropathol Appl Neurobiol 2010;36:90–94.Google Scholar

Guzel, A, Tatli, M, Senturk, S, Guzel, E, Cayli, SR, Sav, A. Pituitary carcinoma presenting with multiple metastases: case report. J Child Neurol 2008;23:1467–1471.Google Scholar

Vidal, S, Kovacs, K, Horvath, E, Scheithauer, BW, Kuroki, T, Lloyd, RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 2001;438:595–602.Google Scholar

Thapar, K, Scheithauer, BW, Kovacs, K, Pernicone, PJ, Laws, ER, Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996;38:765–771.Google Scholar

Jin, L, Qian, X, Kulig, E, et al. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 1997;151:509–519.Google Scholar

Korbonits, M, Chahal, HS, Kaltsas, G, et al. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 2002;87:2635–2643.Google Scholar

Nosé-Alberti, V, Mesquita, MI, Martin, LC, Kayath, MJ. Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 1998;9:53–62.Google Scholar

Pei, L, Melmed, S, Scheithauer, B, Kovacs, K, Prager, D. H-RAS mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 1994;78:842–846.Google Scholar

Cai, WY, Alexander, JM, Hedley-Whyte, ET, et al. RAS mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 1994;78:89–93.Google Scholar

Hinton, DR, Hahn, JA, Weiss, MH, Couldwell, WT. Loss of Rb expression in an ACTH-secreting pituitary carcinoma. Cancer Lett 1998;126:209–214.Google Scholar

Tanizaki, Y, Jin, L, Scheithauer, BW, Kovacs, K, Roncaroli, F, Lloyd, RV. P53 gene mutations in pituitary carcinomas. Endocr Pathol 2007;18:217–222.Google Scholar

Gaffey, TA, Scheithauer, BW, Lloyd, RV, et al. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg 2002;96:352–360.Google Scholar

Lim, S, Shahinian, H, Maya, MM, Yong, W, Heaney, AP. Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 2006;7:518–520.Google Scholar

Fadul, CE, Kominsky, AL, Meyer, LP, et al. Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 2006;105:621–626.Google Scholar

Hagen, C, Schroeder, HD, Hansen, S, Hagen, C, Andersen, M. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Eur J Endocrinol 2009;161:631–637.Google Scholar

Annamalai, AK, Dean, AF, Kandasamy, N, et al. Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary 2012;15:276–287.Google Scholar

Kovacs, K, Scheithauer, BW, Lombardero, M, et al. MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol 2008;115:261–262.Google Scholar

McCormack, A, Kaplan, W, Gill, AJ, et al. MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary 2013;16:208–219.Google Scholar

Bush, ZM, Longtine, JA, Cunningham, T, et al. Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O-methylguanine methyltransferase (MGMT) promoter methylation and expression. J Clin Endocrinol Metab 2010;95:E280–E290.Google Scholar

Frangou, EM, Tynan, JR, Robinson, CA, Ogieglo, LM, Vitali, AM. Metastatic craniopharyngioma: case report and literature review. Childs Nerv Syst 2009;25:1143–1147.Google Scholar

Gupta, K, Kuhn, MJ, Shevlin, DW, Wacaser, LE. Metastatic craniopharyngioma. AJNR Am J Neuroradiol 1999;20:1059–1060.Google Scholar

Grover, WD, Rorke, LB. Invasive craniopharyngioma. J Neurol Neurosurg Psychiatry 1968;31:580–582.Google Scholar

Virik, K, Turner, J, Garrick, R, Sheehy, JP. Malignant transformation of craniopharyngioma. J Clin Neurosci 1999;6:527–530.Google Scholar

Rodriguez, FJ, Scheithauer, BW, Tsunoda, S, Kovacs, K, Vidal, S, Piepgras, DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol 2007;31:1020–1028.Google Scholar

Mariani, L, Schaller, B, Weis, J, Ozdoba, C, Seiler, RW. Esthesioneuroblastoma of the pituitary gland: a clinicopathological entity? Case report and review of the literature. J Neurosurg 2004;101:1049–1052.Google Scholar

Sajko, T, Rumboldt, Z, Talan-Hranilovic, J, Radic, I, Gnjidic, Z. Primary sellar esthesioneuroblastoma. Acta Neurochir (Wien) 2005;147:447–448.Google Scholar

Lin, JH, Tsai, DH, Chiang, YH. A primary sellar esthesioneuroblastomas with unusual presentations: a case report and reviews of literatures. Pituitary 2009;12:70–75.Google Scholar

Oyama, K, Yamada, S, Usui, M, Kovacs, K. Sellar neuroblastoma mimicking pituitary adenoma. Pituitary 2005;8:109–114.Google Scholar

Unger, F, Haselsberger, K, Walch, C, Stammberger, H, Papaefthymiou, G. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien) 2005;147:595–601.Google Scholar

Masse, SR, Wolk, RW, Conklin, RH. Peripituitary gland involvement in acute leukemia in adults. Arch Pathol 1973;96:141–142.Google Scholar

Mancardi, GL, Mandybur, TI. Solitary intracranial plasmacytoma. Cancer 1983;51:2226–2233.Google Scholar

Jacquet, G, Vuillier, J, Viennet, A, Godard, J, Steimle, R. [Solitary plasmacytoma simulating pituitary adenoma.] Neurochirurgie 1991;37:67–71.Google Scholar

Singh, VP, Mahapatra, AK, Dinde, AK. Sellar-suprasellar primary malignant lymphoma: case report. Indian J Cancer 1993;30:88–91.Google Scholar

Samaratunga, H, Perry-Keene, D, Apel, RL. Primary lymphoma of the pituitary gland: a neoplasm of acquired MALT? Endocr Pathol 1997;8:335–341.Google Scholar

Sanchez, JA, Rahman, S, Strauss, RA, Kaye, GI. Multiple myeloma masquerading as a pituitary tumor. Arch Pathol Lab Med 1977;101:55–56.Google Scholar

Nemoto, K, Ohnishi, Y, Tsukada, T. Chronic lymphocytic leukemia showing pituitary tumor with massive leukemic cell infiltration, and special reference to clinicopathological findings of CLL. Acta Pathol Jpn 1978;28:797–805.Google Scholar

Urbanski, SJ, Bilbao, JM, Horvath, E, Kovacs, K, So, W, Ward, JV. Intrasellar solitary plasmacytoma terminating in multiple myeloma: a report of a case including electron microscopical study. Surg Neurol 1980;14:233–236.Google Scholar

Vaquero, J, Areitio, E, Martinez, R. Intracranial parasellar plasmacytoma. Arch Neurol 1982;39:738.Google Scholar

Bitterman, P, Ariza, A, Black, RA, Allen, WEI, Lee, SH. Multiple myeloma mimicking pituitary adenoma. Compt Radiol 1986;10:201–205.Google Scholar

Maiuri, F. Primary cerebral lymphoma presenting as steroid-responsive chiasmal syndrome. Br J Neurosurg 1987;1:499–502.Google Scholar

Sheehan, T, Cuthbert, RJG, Parker, AC. Central nervous system involvement in haematological malignancies. Clin Lab Haematol 1989;11:331–338.Google Scholar

McLaughlin, DM, Gray, WJ, Jones, FG, et al. Plasmacytoma: an unusual cause of a pituitary mass lesion. A case report and a review of the literature. Pituitary 2004;7:179–181.Google Scholar

Sinnott, BP, Hatipoglu, B, Sarne, DH. Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review. Pituitary 2006;9:65–72.Google Scholar

Yaman, E, Benekli, M, Coskun, U, et al. Intrasellar plasmacytoma: an unusual presentation of multiple myeloma. Acta Neurochir (Wien) 2008;150:921–924.Google Scholar

Roggli, VL, Suzuki, M, Armstrong, D, McGavran, MH. Pituitary microadenoma and primarylymphoma of brain associated with hypopthalamic invasion. Am J Clin Pathol 1979;71:724–727.Google Scholar

Warnke, R, Dorfman, R, Weiss, L, Cleary, M, Chan, J. Atlas of Tumor Pathology, 3rd Series, Fascicle 14: Tumors of the Lymphoid System. Washington, DC: Armed Forces Institute of Pathology, 1995.Google Scholar

Jaffe, ES, Harris, NL, Stein, H, Vardiman, JW. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer, 2001.Google Scholar

Favara, BE, Feller, AC, Pauli, M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157–166.Google Scholar

Willman, CL, Busque, L, Griffith, BB, et al. Langerhans-cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med 1994;331:154–160.Google Scholar

Yousem, SA, Colby, TV, Chen, YY, Chen, WG, Weiss, LM. Pulmonary Langerhans cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25:630–636.Google Scholar

Kepes, JJ, Kepes, M. Predominantly cerebral forms of histiocytosis-X. A reappraisal of “Gagel’s hypothalamic granuloma,” “granuloma infiltrans of the hypothalamus” and “Ayala’s disease” with a report of four cases. Acta Neuropathol (Berl) 1969;14:77–98.Google Scholar

Ober, KP, Alexander, E Jr., Challa, VR, Ferree, C, Elster, A. Histiocytosis X of the hypothalamus. Neurosurgery 1989;24:93–95.Google Scholar

Nishio, S, Mizuno, J, Barrow, DL, Takei, Y, Tindall, GT. Isolated histiocytosis X of the pituitary gland: case report. Neurosurgery 1987;21:718–721.Google Scholar

Kovacs, K, Bilbao, JM, Fornasier, VL, Horvath, E. Pituitary pathology in Erdheim–Chester disease. Endocr Pathol 2004;15:159–166.Google Scholar

Mahnel, R, Tan, KH, Fahlbusch, R, et al. Problems in differential diagnosis of non Langerhans cell histiocytosis with pituitary involvement: case report and review of literature. Endocr Pathol 2002;13:361–368.Google Scholar

Vadakekalem, J, Stamos, T, Shenker, Y. Sometimes the hooves do belong to zebras! An unusual case of hypopituitarism. J Clin Endocrinol Metab 1995;80:17–20.Google Scholar

Oweity, T, Scheithauer, BW, Ching, HS, Lei, C, Wong, KP. Multiple system Erdheim–Chester disease with massive hypothalamic–sellar involvement and hypopituitarism. J Neurosurg 2002;96:344–351.Google Scholar

Graif, M, Pennock, JM. MR imaging of histiocytosis X in the central nervous system. AJNR Am J Neuroradiol 1986;7:21–23.Google Scholar PubMed

Peyster, RG, Hoover, ED. CT of the abnormal pituitary stalk. AJNR Am J Neuroradiol 1984;5:49–52.Google Scholar

Tien, RD, Newton, TH, McDermott, MW, Dilon, WP, Kucharczyk, J. Thickened pituitary stalk on MR images in patients with diabetes insipidus and Langerhans cell histiocytosis. AJNR Am J Neuroradiol 1990;11:703–708.Google Scholar

Schmitt, S, Wichmann, W, Martin e, , Zachmann, M, Schoenle, EJ. Primary stalk thickening with dibetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children. Eur J Pediatr 1993;152:399–401.Google Scholar

Ornvold, K, Ralfkiaer, E, Carstensen, H. Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (Histiocytosis X). Virchows Arch A Pathol Anat Histopathol 1990;416:403–410.Google Scholar

Rueda-Pedraza, ME, Heifetz, SA, Sesterhenn, IA, Clark, GB. Primary intracranial germ cell tumors in the first two decades of life. A clinical, light-microscopic, and immunohistochemical analysis of 54 cases. Perspect Pediatr Pathol 1987;10:160–207.Google Scholar

Jennings, MT, Gelman, R, Hochberg, F. Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 1985;63:155–167.Google Scholar

Sakai, N, Yamada, H, Andoh, T, Hirata, T, Shimizu, K, Shinoda, J. Primary intracranial germ-cell tumors. A retrospective analysis with special reference to long-term results of treatment and the behavior of rare types of tumors. Acta Oncol 1988;27:43–50.Google Scholar

Kageyama, N, Kobayashi, T, Kida, Y, Yoshida, J, Kato, K. Intracranial germinal tumors. Prog Exp Tumor Res 1987;30:255–267.Google Scholar

Furukawa, F, Haebara, H, Hamashima, Y. Primary intracranial choriocarcinoma arising from the pituitary fossa. Report of an autopsy case with literature review. Acta Pathol Jpn 1986;36:773–781.Google Scholar

Poon, W, Ng, HK, Wong, K, South, JR. Primary intrasellar germinoma presenting with cavernous sinus syndrome. Surg Neurol 1988;30:402–405.Google Scholar

Ho, KL. Ecchordosis physaliphora and chordoma: a comparative ultrastructural study. Clin Neuropathol 1985;4:77–86.Google Scholar

Sundaresan, N. Chordomas. Clin Orthop Rel Res 1986;204:135–142.Google Scholar

Mathews, W, Wilson, CB. Ectopic intrasellar chordoma. J Neurosurg 1974;39:260–263.Google Scholar

Wold, LE, Laws, ER. Cranial chordomas in children and young adults. J Neurosurg 1983;59:1043–1047.Google Scholar

Heffelfinger, MJ, Dahlin, DC, MacCarty, CS, Beabout, JW. Chordomas and cartilaginous tumors at the skull base. Cancer 1973;32:410–420.Google Scholar

Vujovic, S, Henderson, S, Presneau, N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006;209:157–165.Google Scholar

Castel, JP, Delorge-Kerdiles, C, Rivel, J. Angiome caverneux du chiasma optique. Neurochirurgie 1989;35:252–256.Google Scholar

Sansone, ME, Liwnicz, BH, Mandybur, TI. Giant pituitary cavernous hemangioma. Case report. J Neurosurg 1980;53:124–126.Google Scholar

Chang, WH, Khosla, VK, Radotra, BD, Kak, VK. Large cavernous hemangioma of the pituitary fossa: a case report. Br J Neurosurg 1991;5:627–629.Google Scholar

Asa, SL, Kovacs, K, Horvath, E, Ezrin, C, Weiss, MH. Sellar glomangioma. Ultrastruct Pathol 1984;7:49–54.Google Scholar

Dan, NG, Smith, DE. Pituitary hemangioblastoma in a patient with von Hippel–Lindau disease. J Neurosurg 1975;42:232–235.Google Scholar

Goto, T, Nishi, T, Kunitoku, N, et al. Suprasellar hemangioblastoma in a patient with von Hippel–Lindau disease confirmed by germline mutation study: case report and review of the literature. Surg Neurol 2001;56:22–26.Google Scholar

Cassarino, DS, Auerbach, A, Rushing, EJ. Widely invasive solitary fibrous tumor of the sphenoid sinus, cavernous sinus, and pituitary fossa. Ann Diagn Pathol 2003;7:169–173.Google Scholar

Furlanetto, TW, Pinheiro, CF, Oppitz, PP, de Alencastro, LC, Asa, SL. Solitary fibrous tumor of the sella mimicking pituitary adenoma: an uncommon tumor in a rare location-a case report. Endocr Pathol 2009;20:56–61.Google Scholar

Wu, KK, Ross, PM, Mitchell, DC, Sprague, HH. Evolution of a case of multicentric giant cell tumor over a 23-year period. Clin Orthop Rel Res 1986;213:279–288.Google Scholar

Wolfe, JTI, Scheithauer, BW, Dahlin, DC. Giant-cell tumor of the sphenoid bone. Review of 10 cases. J Neurosurg 1983;59:322–327.Google Scholar

Viswanathan, R, Jegathraman, AR, Ganapathy, K, Bharati, AS, Govindan, R. Parasellar chondromyxofibroma with ipsilateral total internal carotid artery occlusion. Surg Neurol 1987;28:141–144.Google Scholar

Angiari, P, TTorcia, E, Botticelli, RA, villani, M, Merli, GA, Crisi, G. Ossifying parasellar chondroma. Case report. J Neursurg Sci 1987;31:59–63.Google Scholar

Dutton, J. Intracranial solitary chondroma. Case report. J Neurosurg 1978;49:460–463.Google Scholar

Inoue, T, Takahashi, N, Murakami, K, Nishimura, S, Kaimori, M, Nishijima, M. Osteochondroma of the sella turcica presenting with intratumoral hemorrhage. Neurol Med Chir (Tokyo) 2009;49:37–41.Google Scholar

Miki, K, Kawamoto, K, Kawamura, Y, Matsumura, H, Asada, Y, Hamada, A. A rare case of Maffucci’s syndrome combined with tuberculum sellae enchondroma, pituitary adenoma and thyroid adenoma. Acta Neurochir 1987;87:79–85.Google Scholar

Sindou, M, Daher, A, Vighetto, A, Goutelle, A. Chondrosarcome parasellaire: rapport d’un cas opéré par voie ptériono-temporale et revue de la littérature. Neurochirurgie 1989;35:186–190.Google Scholar

Bots, GTAM, Tijssen, CC, Wijnalda, D, Teepen, JLJM. Alveolar soft part sarcoma of the pituitary gland with secondary involvement of the right cerebral ventricle. Br J Neurosurg 1988;2:101–107.Google Scholar

Gerlach, H, Jänisch, W. Intrakranielles Sarkom nach Bestrahlung eines Hypophysenadenoms. Zentralbl Neurochir 1979;40:131–136.Google Scholar

Ahmad, K, Fayos, JV. Pituitary fibrosarcoma secondary to radiation therapy. Cancer 1978;42:107–110.Google Scholar

Amine, ARC, Sugar, O. Suprasellar osteogenic sarcoma following radiation for pituitary adenoma. Case report. J Neurosurg 1976;44:88–91.Google Scholar

Powell, HC, Marshall, LF, Ignelzi, RJ. Post-irradiation pituitary sarcoma. Acta Neuropathol (Berl) 1977;39:165–167.Google Scholar

Tanaka, S, Nishio, S, Morioka, T, Fukui, M, Kitamura, K, Hikita, K. Radiation-induced osteosarcoma of the sphenoid bone. Neurosurgery 1989;25:640–643.Google Scholar

Yamamoto, A, Hashimoto, N, Yamashita, J, Kikuchi, H. A case of radiation-induced intracranial fibrosarcoma with repeated episodes of intratumoral hemorrhage. Neurol Surg 1989;17:193–196.Google Scholar

Max, MB, Deck, MDF, Rottenberg, DA. Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 1981;31:998–1002.Google Scholar

Roessmann, U, Kaufman, B, Friede, RL. Metastatic lesions in the sella turcica and pituitary gland. Cancer 1970;25:478–480.Google Scholar

Felix, IA. Pathology of the neurohypophysis. Pathol Res Pract 1988;183:535–537.Google Scholar

Branch, CL Jr., Laws, ER Jr. Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 1987;65:469–474.Google Scholar

de la Monte, SM, Hutchins, GM, Moore, GW. Endocrine organ metastases from breast carcinoma. Am J Pathol 1984;114:131–136.Google Scholar

Kattah, JC, Silgals, RM, Manz, HJ, Toro, JG, Dritschilo, A, Smith, FP. Presentation and management of parasellar and suprasellar metastatic mass lesions. J Neurol Neurosurg Psychiatry 1985;48:44–49.Google Scholar

Allen, EM, Kannan, SR, Powell, A. Infundibular metastasis and panhypopituitarism. J Natl Med Assoc 1989;81:325–330.Google Scholar

McCormick, PC, Post, KD, Kandji, AD, Hays, AP. Metastatic carcinoma to the pituitary gland. Br J Neurosurg 1989;3:71–79.Google Scholar

van Seters, AP, Bots, GTAM, Van Dulken, H, Luyendijk, W, Vielvoye, GJ. Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature. Neurosurgery 1985;16:813–817.Google Scholar

Post, KD, McCormick, PC, Hays, AP, Kankji, AD. Metastatic carcinoma to pituitary adenoma. Report of two cases. Surg Neurol 1988;30:286–292.Google Scholar

Molinatti, PA, Scheithauer, BW, Randall, RV, Laws, ER Jr. Metastasis to pituitary adenoma. Arch Pathol Lab Med 1985;109:287–289.Google Scholar

Zager, EL, Hedley-White, ET. Metastasis within a pituitary adenoma presenting with bilateal abducens palsies: cae report and review of the literature. Neurosurgery 1987;21:383–386.Google Scholar

James, RL, Arsenis, G, Stoler, M, Nelson, C, Baran, D. Hypophyseal metastatic renal cell carcinoma and pituitary adenoma. Case report and review of the literature. Am J Med 1984;76:337–340.Google Scholar

Ramsay, JA, Kovacs, K, Scheithauer, BW, Ezrin, C, Weiss, MH. Metastatic carcinoma to pituitary adenomas: a report of two cases. Exper Clin Endocrinol 1988;92:69–76.Google Scholar

Santarpia, L, Gagel, RF, Sherman, SI, Sarlis, NJ, Evans, DB, Hoff, AO. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. Head Neck 2009;31:419–423.Google Scholar

Williams, MD, Asa, SL, Fuller, GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol 2008;12:199–203.Google Scholar

Neilson, JM, Moffat, AD. Hypopituitarism caused by a melanoma of the pituitary gland. J Clin Pathol 1963;16:144–149.Google Scholar

Scholtz, CL, Siu, K. Melanoma of the pituitary. Case report. J Neurosurg 1976;45:101–103.Google Scholar

Copeland, DD, Sink, JD, Seigler, HF. Primary intracranial melanoma presenting as a suprasellar tumor. Neurosurgery 1980;6:542–545.Google Scholar

Chappell, PM, Kelly, WM, Ercius, M. Primary sellar melanoma simulating hemorrhagic pituitary adenoma: MR and pathologic findings. AJNR Am J Neuroradiol 1990;11:1054–1056.Google Scholar

Aubin, MJ, Hardy, J, Comtois, R. Primary sellar haemorrhagic melanoma: case report and review of the literature. Br J Neurosurg 1997;11:80–83.Google Scholar

Borek, BT, McKee, PH, Freeman, JA, Maguire, B, Brander, WL, Calonje, E. Primary malignant melanoma with rhabdoid features: a histologic and immunocytochemical study of three cases. Am J Dermatopathol 1998;20:123–127.Google Scholar

Tuttenberg, J, Fink, W, Back, W, Wenz, F, Schadendorf, D, Thome, C. A rare primary sellar melanoma. Case report. J Neurosurg 2004;100:931–934.Google Scholar

Rousseau, A, Bernier, M, Kujas, M, Varlet, P. Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature. Neurosurgery 2005;57:E369.Google Scholar

Bell, CD, Kovacs, K, Horvath, E, Smythe, H, Asa, S. Papillary carcinoma of thyroid metastatic to the pituitary gland. Arch Pathol Lab Med 2001;125:935–938.Google Scholar

Book contents

Chapter 12 - The pituitary gland

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive